<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">IJT</journal-id>
<journal-id journal-id-type="hwp">spijt</journal-id>
<journal-id journal-id-type="nlm-ta">Int J Toxicol</journal-id>
<journal-title>International Journal of Toxicology</journal-title>
<issn pub-type="ppub">1091-5818</issn>
<issn pub-type="epub">1092-874X</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1091581811429865</article-id>
<article-id pub-id-type="publisher-id">10.1177_1091581811429865</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Correlation Between In Silico Physicochemical Characteristics of Drugs and Their Mean Residence Time in Human and Dog</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Grabowski</surname>
<given-names>Tomasz</given-names>
</name>
<xref ref-type="aff" rid="aff1-1091581811429865">1</xref>
<xref ref-type="corresp" rid="corresp1-1091581811429865"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jaroszewski</surname>
<given-names>Jerzy Jan</given-names>
</name>
<xref ref-type="aff" rid="aff2-1091581811429865">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gad</surname>
<given-names>Shayne Cox</given-names>
</name>
<xref ref-type="aff" rid="aff3-1091581811429865">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Feder</surname>
<given-names>Marcin</given-names>
</name>
<xref ref-type="aff" rid="aff4-1091581811429865">4</xref>
</contrib>
</contrib-group>
<aff id="aff1-1091581811429865"><label>1</label>Centre of Pharmacokinetics Research FILAB, Ravimed Sp. z o.o., Polna 54, 05-119 Łajski, Poland</aff>
<aff id="aff2-1091581811429865"><label>2</label>Department of Pharmacology and Toxicology, Faculty of Veterinary Medicine, University of Warmia and Mazury, Oczapowskiego 13, 10-718 Olsztyn, Poland</aff>
<aff id="aff3-1091581811429865"><label>3</label>Gad Consulting Services, North Carolina, USA</aff>
<aff id="aff4-1091581811429865"><label>4</label>Department of Research and Development, ADAMED Sp. z o.o., Pieńków 149 05-152 Czosnów, Poland</aff>
<author-notes>
<corresp id="corresp1-1091581811429865">Tomasz Grabowski, Centre of Pharmacokinetics Research FILAB, Ravimed Sp. z o.o., Polna 54, 05-119 Łajski, Poland Email: <email>tomasz.grabowski@polpharma.com.pl</email>
</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>1</month>
<year>2012</year>
</pub-date>
<volume>31</volume>
<issue>1</issue>
<fpage>25</fpage>
<lpage>33</lpage>
<permissions>
<copyright-statement>© American College of Toxicology 2011</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">American College of Toxicology</copyright-holder>
</permissions>
<abstract>
<p>The correlation between 52 physicochemical parameters and mean residence time (MRT) for 27 drugs used in human and dog were investigated. The physicochemical parameter values calculated provided a basis for deriving a series of arithmetic expressions, which were used to build a mathematical model describing the relationship between them and the MRT values. From the entire set of analyzed parameters, a subset of 14 was identified that contributed to the derivation of an arithmetic expression:</p>
<p>
<disp-formula id="disp-formula1-1091581811429865">
<mml:math id="mml-disp1-1091581811429865">
<mml:mtable columnalign="right left" columnspacing="thickmathspace" displaystyle="true" rowspacing=".5em">
<mml:mtr>
<mml:mtd>
</mml:mtd>
<mml:mtd>
<mml:mi>L</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>g</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>P</mml:mi>
<mml:mi>S</mml:mi>
<mml:mi>A</mml:mi>
<mml:mo stretchy="false">−</mml:mo>
<mml:mi>W</mml:mi>
<mml:mi>P</mml:mi>
<mml:mi>S</mml:mi>
<mml:mi>A</mml:mi>
<mml:mo stretchy="false">+</mml:mo>
<mml:mi>A</mml:mi>
<mml:mi>C</mml:mi>
<mml:mi>I</mml:mi>
<mml:mi>D</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">×</mml:mo>
<mml:mo stretchy="false">[</mml:mo>
<mml:mi>X</mml:mi>
<mml:mi>L</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>g</mml:mi>
<mml:mi>P</mml:mi>
<mml:mo stretchy="false">−</mml:mo>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>L</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>g</mml:mi>
<mml:mi>K</mml:mi>
<mml:mi>p</mml:mi>
<mml:mo stretchy="false">−</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">E</mml:mi>
<mml:mi mathvariant="normal">A</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">×</mml:mo>
<mml:mi>L</mml:mi>
<mml:mi>n</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>C</mml:mi>
<mml:mi>a</mml:mi>
<mml:mi>c</mml:mi>
<mml:mi>o</mml:mi>
<mml:mn>2</mml:mn>
<mml:mo stretchy="false">+</mml:mo>
<mml:mi>A</mml:mi>
<mml:mi>M</mml:mi>
<mml:mi>I</mml:mi>
<mml:mi>N</mml:mi>
<mml:mi>E</mml:mi>
<mml:mo stretchy="false">+</mml:mo>
<mml:mi>S</mml:mi>
<mml:mi>A</mml:mi>
<mml:mi>F</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">]</mml:mo>
<mml:mo stretchy="false">+</mml:mo>
</mml:mtd>
</mml:mtr>
<mml:mtr>
<mml:mtd>
</mml:mtd>
<mml:mtd>
<mml:mo stretchy="false">+</mml:mo>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>A</mml:mi>
<mml:mi>M</mml:mi>
<mml:mi>I</mml:mi>
<mml:mi>D</mml:mi>
<mml:mi>E</mml:mi>
<mml:mo stretchy="false">+</mml:mo>
<mml:mi>I</mml:mi>
<mml:mi>P</mml:mi>
<mml:mo stretchy="false">−</mml:mo>
<mml:mi>F</mml:mi>
<mml:mi>G</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">−</mml:mo>
<mml:mi>L</mml:mi>
<mml:mi>n</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>M</mml:mi>
<mml:mi>W</mml:mi>
<mml:mo stretchy="false">+</mml:mo>
<mml:mi>P</mml:mi>
<mml:mi>I</mml:mi>
<mml:mi>S</mml:mi>
<mml:mi>A</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
</mml:mtd>
</mml:mtr>
</mml:mtable>
</mml:math>
<graphic alternate-form-of="disp-formula1-1091581811429865" xlink:href="10.1177_1091581811429865-eq1.tif"/>
</disp-formula>
</p>
<p>the value of which is highly correlated with the MRT value in dogs (<italic>P</italic> &lt; .001) and allowed prediction of the MRT predicted (MRT<sub>(pred)</sub>). In humans, no correlation was found that allowed the calculation of MRT<sub>(pred)</sub>. These results indicate that predicting the pharmacokinetics of any specific drug for humans based on pharmacokinetic data obtained in the dog should be undertaken with knowledge of the inherent limitations.</p>
</abstract>
<kwd-group>
<kwd>mean residence time</kwd>
<kwd>elimination half-life</kwd>
<kwd>in silico</kwd>
<kwd>pharmacokinetics</kwd>
<kwd>species differences</kwd>
</kwd-group>
<custom-meta-wrap>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>January/February 2012</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="section1-1091581811429865">
<title>Introduction</title>
<p>Mean residence time (MRT) and half-life in elimination phase (t<sub>1/2kel</sub>) are the key pharmacokinetic parameters describing elimination of a drug from the body. The elimination half-life in the in vivo studies is usually determined based on the last 3 to 4 points obtained on the concentration versus (vs) time curve created for the analyzed drug.<sup><xref ref-type="bibr" rid="bibr1-1091581811429865">
1</xref></sup> These values/points are qualified for the analysis by the person performing it. Based on these selected points, the elimination rate constant (k<sub>el</sub>) is calculated using least-squares analysis, and the value of t<sub>1/2kel</sub> is determined based on the k<sub>el</sub>. The determination of t<sub>1/2kel</sub> often bears a significant error. The reasons for that are numerous, for example: (<italic>a</italic>) the sampling period in the study is too short; (<italic>b</italic>) the lower limit of quantification (LLOQ) for the analytical method is too high; the LLOQ is higher than the concentration value obtained in the last sampling point; (<italic>c</italic>) sampling points in the elimination phase are distributed incorrectly; (<italic>d</italic>) the selection of points on the concentration versus time (C-T) curve for calculating t<sub>1/2kel</sub> is incorrect; (<italic>e</italic>) there are fluctuations on the C-T curve in the elimination phase, for example, due to enterohepatic circulation, and so on.<sup><xref ref-type="bibr" rid="bibr2-1091581811429865">
2</xref></sup>
</p>
<p>As to MRT, this parameter is calculated based on the values of area under the curve (AUC) and area under the first moment curve (AUMC). Therefore, the MRT calculation from data obtained in in vivo experiments is not related in any way to specific parts of the C-T curve but rather to all observations starting after the absorption phase until the end of drug elimination. The MRT calculation with the use of the equation <inline-formula id="inline-formula1-1091581811429865">
<mml:math id="mml-inline1-1091581811429865">
<mml:mo stretchy="false">[</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">M</mml:mi>
<mml:mi mathvariant="normal">R</mml:mi>
<mml:mi mathvariant="normal">T</mml:mi>
<mml:mo mathvariant="normal" stretchy="false">=</mml:mo>
<mml:mi mathvariant="normal">A</mml:mi>
<mml:mi mathvariant="normal">U</mml:mi>
<mml:mi mathvariant="normal">M</mml:mi>
<mml:mi mathvariant="normal">C</mml:mi>
<mml:mrow>
<mml:mo>/</mml:mo>
</mml:mrow>
<mml:mi mathvariant="normal">A</mml:mi>
<mml:mi mathvariant="normal">U</mml:mi>
<mml:mi mathvariant="normal">C</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">]</mml:mo>
</mml:math>
</inline-formula> usually does not contribute any significant error as opposed to t<sub>1/2kel</sub> calculation. For the typical one-compartmental model after single intravenous (IV) administration this resolves to <inline-formula id="inline-formula2-1091581811429865">
<mml:math id="mml-inline2-1091581811429865">
<mml:mo stretchy="false">[</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">M</mml:mi>
<mml:mi mathvariant="normal">R</mml:mi>
<mml:mi mathvariant="normal">T</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">=</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mn mathvariant="normal">1</mml:mn>
<mml:mrow>
<mml:mo>/</mml:mo>
</mml:mrow>
</mml:mrow>
</mml:mrow>
<mml:msub>
<mml:mi>k</mml:mi>
<mml:mrow>
<mml:mi>e</mml:mi>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">]</mml:mo>
</mml:math>
</inline-formula>. Precise calculation of parameters related to drug elimination enables the confirmation of bioequivalence, determination of correct dosing of the drug as well as waiting periods, the analysis of drug accumulation in the body, and possible risks related to that dose.<sup><xref ref-type="bibr" rid="bibr3-1091581811429865">
3</xref>,<xref ref-type="bibr" rid="bibr4-1091581811429865">4</xref>
</sup>
</p>
<p>Drug elimination is a result of several different processes occurring simultaneously within the body. In many cases, it can be additionally modified by the processes of reabsorption caused by the circulation of the drug with lymph, bile, or saliva; metabolic induction; chiral inversion; resorption in renal tubules; reabsorption being a result of enzymatic decomposition conducted by intestinal flora and other metabolic processes.<sup><xref ref-type="bibr" rid="bibr5-1091581811429865">
5</xref><xref ref-type="bibr" rid="bibr6-1091581811429865"/><xref ref-type="bibr" rid="bibr7-1091581811429865"/>–<xref ref-type="bibr" rid="bibr8-1091581811429865">8</xref>
</sup>
</p>
<p>Currently some of the pharmacokinetic parameters, processes, and phenomena observed in vivo are believed to be primarily determined by or associated with the molecular structure of the drug. The examples of such attempts include the analysis of the relationship between molecular structure of the drug and its enterohepatic circulation,<sup><xref ref-type="bibr" rid="bibr9-1091581811429865">
9
</xref>,<xref ref-type="bibr" rid="bibr10-1091581811429865">10</xref>
</sup> volume of distribution,<sup><xref ref-type="bibr" rid="bibr11-1091581811429865">
11</xref>,<xref ref-type="bibr" rid="bibr12-1091581811429865">12</xref>
</sup> clearance<sup><xref ref-type="bibr" rid="bibr13-1091581811429865">
13</xref><xref ref-type="bibr" rid="bibr14-1091581811429865"/><xref ref-type="bibr" rid="bibr15-1091581811429865"/>–<xref ref-type="bibr" rid="bibr16-1091581811429865">16</xref>
</sup> elimination half-life,<sup><xref ref-type="bibr" rid="bibr17-1091581811429865">
17
</xref></sup> and/or absolute bioavailability.<sup><xref ref-type="bibr" rid="bibr18-1091581811429865">
18</xref><xref ref-type="bibr" rid="bibr19-1091581811429865"/><xref ref-type="bibr" rid="bibr20-1091581811429865"/>–<xref ref-type="bibr" rid="bibr21-1091581811429865">21</xref>
</sup> Such studies are usually performed in relation to data from in vivo experiments conducted in a single species and/or with the use of data from a limited group of homologous drugs.</p>
<p>Therefore, the aim of this study was an attempt to find a correlation between physicochemical characteristics of a drug and its MRT determined in vivo both in human and in dog for the group of drugs of diverse molecular structure and pharmacological effects.</p>
</sec>
<sec id="section2-1091581811429865">
<title>Materials and Methods</title>
<sec id="section3-1091581811429865">
<title>Tested Group of Drugs</title>
<p>The analysis was performed using a group of 27 drugs, for which the MRT (as statistical moment: <inline-formula id="inline-formula3-1091581811429865">
<mml:math id="mml-inline3-1091581811429865">
<mml:mo stretchy="false">[</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">M</mml:mi>
<mml:mi mathvariant="normal">R</mml:mi>
<mml:mi mathvariant="normal">T</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">=</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">A</mml:mi>
<mml:mi mathvariant="normal">U</mml:mi>
<mml:mi mathvariant="normal">M</mml:mi>
<mml:mi mathvariant="normal">C</mml:mi>
<mml:mrow>
<mml:mo>/</mml:mo>
</mml:mrow>
<mml:mi mathvariant="normal">A</mml:mi>
<mml:mi mathvariant="normal">U</mml:mi>
<mml:mi mathvariant="normal">C</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">]</mml:mo>
</mml:math>
</inline-formula>) and t<sub>1/2kel</sub> values were determined after single IV administration in both human and dog. Presence of t<sub>1/2kel</sub> in the analyzed set of data confirms in vivo sampling in proper range (sampling time ≥3 × <italic>t</italic>
<sub>1/2<italic>ke1</italic>
</sub>). The data were drawn from scientific literature (listed in <xref ref-type="table" rid="table1-1091581811429865">Table 1</xref>
).</p>
<table-wrap id="table1-1091581811429865" position="float">
<label>Table 1.</label>
<caption>
<p>Values of Mean Residence Time (MRT) and Half-Life in Elimination Phase (t<sub>1/2kel</sub>) for the group of 27 Drugs Administered Intravenously in Human<sup>22</sup> and dog</p>
</caption>
<graphic alternate-form-of="table1-1091581811429865" xlink:href="10.1177_1091581811429865-table1.tif"/>
<table>
<thead>
<tr>
<th rowspan="2">No</th>
<th colspan="2" rowspan="2">Substance/CAS number</th>
<th colspan="2">Man</th>
<th colspan="3">Dog</th>
</tr>
<tr>
<th>MRT, hours</th>
<th>t<sub>1/2kel</sub>, hours</th>
<th>MRT, hours</th>
<th>t<sub>1/2kel</sub>, hours</th>
<th>Literature</th>
</tr>
</thead>
<tbody>
<tr>
<td>1</td>
<td>Cyclosporine</td>
<td>59865-13-3</td>
<td>7.3</td>
<td>7.3</td>
<td>25.73</td>
<td>22.56</td>
<td><xref ref-type="bibr" rid="bibr23-1091581811429865">23</xref></td>
</tr>
<tr>
<td>2</td>
<td>Amikacin</td>
<td>38859-32-4</td>
<td>2.4</td>
<td>2.4</td>
<td>1.03</td>
<td>0.81</td>
<td><xref ref-type="bibr" rid="bibr24-1091581811429865">24</xref></td>
</tr>
<tr>
<td>3</td>
<td>Pravastatin</td>
<td>81131-70-6</td>
<td>0.59</td>
<td>0.78</td>
<td>2.1</td>
<td>4</td>
<td><xref ref-type="bibr" rid="bibr25-1091581811429865">25</xref></td>
</tr>
<tr>
<td>4</td>
<td>Carvedilol</td>
<td>72956-09-3</td>
<td>2.8</td>
<td>2.4</td>
<td>6</td>
<td>4.7</td>
<td><xref ref-type="bibr" rid="bibr26-1091581811429865">26</xref></td>
</tr>
<tr>
<td>5</td>
<td>Cefoperazone</td>
<td>72448-63-6</td>
<td>2.2</td>
<td>1.8</td>
<td>1.55</td>
<td>1.4</td>
<td><xref ref-type="bibr" rid="bibr27-1091581811429865">27</xref></td>
</tr>
<tr>
<td>6</td>
<td>Clindamycin</td>
<td>24696-19-3</td>
<td>2.9</td>
<td>2.1</td>
<td>5.1</td>
<td>4.37</td>
<td><xref ref-type="bibr" rid="bibr28-1091581811429865">28</xref></td>
</tr>
<tr>
<td>7</td>
<td>Cefamandole</td>
<td>34444-01-4</td>
<td>0.75</td>
<td>0.75</td>
<td>1.67</td>
<td>1.36</td>
<td><xref ref-type="bibr" rid="bibr27-1091581811429865">27</xref></td>
</tr>
<tr>
<td>8</td>
<td>Albuterol</td>
<td>35763-26-9</td>
<td>4.1</td>
<td>2.4</td>
<td>4</td>
<td>6.07</td>
<td><xref ref-type="bibr" rid="bibr29-1091581811429865">29</xref></td>
</tr>
<tr>
<td>9</td>
<td>Tenofovir<sup>
<xref ref-type="table-fn" rid="table-fn3-1091581811429865">a</xref>
</sup>
</td>
<td>147127-20-6</td>
<td>3.8</td>
<td>5.8</td>
<td>2.62</td>
<td>4.51</td>
<td><xref ref-type="bibr" rid="bibr30-1091581811429865">30</xref></td>
</tr>
<tr>
<td>10</td>
<td>Doxycycline</td>
<td>94088-85-4</td>
<td>25</td>
<td>14</td>
<td>15.12</td>
<td>10.36</td>
<td>
<xref ref-type="bibr" rid="bibr31-1091581811429865">31</xref>
</td>
</tr>
<tr>
<td>11</td>
<td>Cefprozil</td>
<td>92665-29-7</td>
<td>1.2</td>
<td>1.2</td>
<td>1.6</td>
<td>1.17</td>
<td><xref ref-type="bibr" rid="bibr32-1091581811429865">32</xref>
</td>
</tr>
<tr>
<td>12</td>
<td>Probenecid</td>
<td>57-66-9</td>
<td>8.7</td>
<td>5.9</td>
<td>23</td>
<td>18</td>
<td>
<xref ref-type="bibr" rid="bibr33-1091581811429865">33</xref>
</td>
</tr>
<tr>
<td>13</td>
<td>Buprenorphine</td>
<td>52485-79-7</td>
<td>4.9</td>
<td>3.2</td>
<td>4.4</td>
<td>4.44</td>
<td>
<xref ref-type="bibr" rid="bibr34-1091581811429865">34</xref>
</td>
</tr>
<tr>
<td>14</td>
<td>Quinidine</td>
<td>56-54-2</td>
<td>12</td>
<td>6.6</td>
<td>3.34</td>
<td>3.46</td>
<td><xref ref-type="bibr" rid="bibr35-1091581811429865">35</xref>
</td>
</tr>
<tr>
<td>15</td>
<td>Cephalexin</td>
<td>66905-57-5</td>
<td>0.89</td>
<td>0.57</td>
<td>1.38</td>
<td>1.43</td>
<td>
<xref ref-type="bibr" rid="bibr36-1091581811429865">36</xref>
</td>
</tr>
<tr>
<td>16</td>
<td>Ketoprofen</td>
<td>22161-86-0</td>
<td>1.4</td>
<td>2.1</td>
<td>2.2</td>
<td>0.61</td>
<td>
<xref ref-type="bibr" rid="bibr37-1091581811429865">37</xref>
</td>
</tr>
<tr>
<td>17</td>
<td>Tramadol</td>
<td>53611-16-8</td>
<td>7.2</td>
<td>5.8</td>
<td>2.63</td>
<td>2.24</td>
<td>
<xref ref-type="bibr" rid="bibr38-1091581811429865">38</xref>
</td>
</tr>
<tr>
<td>18</td>
<td>Butorphanol</td>
<td>42408-82-2</td>
<td>5.3</td>
<td>4.8</td>
<td>1.87</td>
<td>2.87</td>
<td>
<xref ref-type="bibr" rid="bibr29-1091581811429865">29</xref>
</td>
</tr>
<tr>
<td>19</td>
<td>Ketorolac</td>
<td>74103-06-3</td>
<td>5.2</td>
<td>5.1</td>
<td>8.39</td>
<td>4.55</td>
<td>
<xref ref-type="bibr" rid="bibr39-1091581811429865">39</xref>
</td>
</tr>
<tr>
<td>20</td>
<td>Propofol</td>
<td>82597-74-8</td>
<td>2.2</td>
<td>3.2</td>
<td>1.65</td>
<td>1.4</td>
<td>
<xref ref-type="bibr" rid="bibr40-1091581811429865">40</xref>
</td>
</tr>
<tr>
<td>21</td>
<td>Fosfomycin</td>
<td>26016-99-9</td>
<td>2.7</td>
<td>1.9</td>
<td>1.62</td>
<td>1.28</td>
<td>
<xref ref-type="bibr" rid="bibr41-1091581811429865">41</xref>
</td>
</tr>
<tr>
<td>22</td>
<td>Acetaminophen</td>
<td>8/1/8055</td>
<td>3.3</td>
<td>2.5</td>
<td>0.48</td>
<td>0.37</td>
<td>
<xref ref-type="bibr" rid="bibr42-1091581811429865">42</xref>
</td>
</tr>
<tr>
<td>23</td>
<td>Codeine</td>
<td>76-57-3</td>
<td>3.9</td>
<td>4</td>
<td>1.36</td>
<td>1.28</td>
<td>
<xref ref-type="bibr" rid="bibr43-1091581811429865">43</xref>
</td>
</tr>
<tr>
<td>24</td>
<td>Morphine</td>
<td>57-27-2</td>
<td>1.5</td>
<td>2</td>
<td>1.36</td>
<td>1.16</td>
<td>
<xref ref-type="bibr" rid="bibr44-1091581811429865">44</xref>
</td>
</tr>
<tr>
<td>25</td>
<td>Didanosine<sup><xref ref-type="table-fn" rid="table-fn4-1091581811429865">b</xref></sup>
</td>
<td>69655-05-6</td>
<td>1.2</td>
<td>1.4</td>
<td>0.67</td>
<td>0.99</td>
<td>
<xref ref-type="bibr" rid="bibr45-1091581811429865">45</xref>
</td>
</tr>
<tr>
<td>26</td>
<td>Moxifloxacin</td>
<td>151096-09-2</td>
<td>9.7</td>
<td>8.2</td>
<td>13</td>
<td>8.6</td>
<td>
<xref ref-type="bibr" rid="bibr46-1091581811429865">46</xref>
</td>
</tr>
<tr>
<td>27</td>
<td>Hydromorphone</td>
<td>466-99-9</td>
<td>2.6</td>
<td>2.3</td>
<td>1.22</td>
<td>1</td>
<td>
<xref ref-type="bibr" rid="bibr47-1091581811429865">47</xref>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn3-1091581811429865">
<p>
<sup>a</sup> (9-[(R)-2-(phosphonomethoxy)propyl]adenine).</p>
</fn>
<fn id="table-fn4-1091581811429865">
<p>
<sup>b</sup> (2',3'-dideoxyinosine).</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section4-1091581811429865">
<title>In Silico Calculations</title>
<p>The analysis of the selected physiochemical parameters of the proposed structures was preceded by the transformation of a traditional chemical structure record to sdf files. The properties and descriptors of analyzed structures were predicted using QikProp 3.1 from Schrödinger package (v 31207). QikProp was run in normal mode. The three-dimensional structures of compounds were prepared in LigPrep 2.2 using settings recommended in the QikProp's user manual. In the case of compounds that are chiral or undergo tautomerization up to 32 stereoisomers were generated for each compound or tautomer. The software allowed the calculation of the following 51 parameters: stars—the number of property or descriptor values that fall outside the 95% range of similar values for known drugs; AMINE—number of nonconjugated amine groups; amidine—number of amidine and guanidine groups; ACID—number of carboxylic acid groups; AMIDE—number of nonconjugated amide groups; rotor—number of nontrivial (not CX3), nonhindered (not alkene, amide, small ring) rotatable bonds; FG—number of reactive functional groups; CNSa—predicted central nervous system activity on a −2 (inactive) to +2 (active) scale; MW—molecular weight of the molecule; p—computed dipole moment of the molecule; SASA—total solvent accessible surface area in square angstroms using a probe with a 1.4 Å radius; FOSA—hydrophobic component of the SASA (saturated carbon and attached hydrogen); FISA—hydrophilic component of the SASA (SASA on N, O, and H on heteroatoms); PISA—π (carbon and attached hydrogen) component of the SASA; WPSA—weakly polar component of the SASA (halogens, P, and S); volume—total solvent-accessible volume in cubic angstroms using a probe with a 1.4 Å radius; HBD—estimated number of hydrogen bonds that would be donated by the solute to water molecules in an aqueous solution.; HBA—estimated number of hydrogen bonds that would be accepted by the solute from water molecules in an aqueous solution; dip2/V—square of the dipole moment divided by the molecular volume; ACxDN5/SA—index of cohesive interaction in solids; Glob—globularity descriptor; α—predicted polarizability in cubic angstroms; QPlogPC16—predicted hexadecane/gas partition coefficient; QPlogPoct‡—predicted octanol/gas partition coefficient; QPlogPw—predicted water/gas partition coefficient; QPlogPo/w—predicted octanol/water partition coefficient; QPlogS—predicted aqueous solubility; CIQPlogS—conformation-independent predicted aqueous solubility; QPlogHERG—predicted IC50 value for blockage of HERG K+ channels; Caco2—predicted apparent Caco2 cell permeability in nm/sec; QPlogBB—predicted brain/blood partition coefficient; QPPMDCK—predicted apparent MDCK cell permeability in nm/sec; LogKp—predicted skin permeability; IP—calculated ionization potential; EA—calculated electron affinity; #metab—number of likely metabolic reactions; QPlogKhsa—prediction of binding to human serum albumin; HumanOralAbsorption—predicted qualitative human oral absorption; PercentHuman-OralAbsorption—predicted human oral absorption on 0% to 100% scale; SAF—solvent-accessible surface area of fluorine atoms; SAamideO—solvent-accessible surface area of amide oxygen atoms; PSA—Van der Waals surface area of polar nitrogen and oxygen atoms; NandO—number of nitrogen and oxygen atoms; RuleOfFive—number of violations of Lipinski’s rule of 5; Rule Of Three—number of violations of Jorgensen’s rule of 3; ringatoms—number of atoms in a ring; in34—number of atoms in 3- or 4-membered rings; in56—number of atoms in 5- or 6-membered rings; noncon—number of ring atoms not able to form conjugated aromatic systems; #nonHatm—number of heavy atoms (nonhydrogen atoms); and Jm—the predicted maximum transdermal transport rate. The values of the partition coefficient octanol/water (XLogP) for the analyzed group of drugs were drawn from PubMed database.<sup><xref ref-type="bibr" rid="bibr48-1091581811429865">
48
</xref></sup>
</p>
</sec>
<sec id="section5-1091581811429865">
<title>Creation of Expressions</title>
<p>While searching for a correlation between the grouped in silico parameters and the MRT value, a number of arithmetic expressions were created. Overall, several forms of different expressions were analyzed. <xref ref-type="table" rid="table2-1091581811429865">Table 2</xref>
presents an example of designing such expressions. By successively incorporating various physicochemical parameter values a series of arithmetic expressions was derived. The arithmetic expressions were constructed but not based on the values of individual parameters but rather by combining several of the parameters together (<xref ref-type="fig" rid="fig1-1091581811429865">Figure 1</xref>
). The equation derived served as a means to calculate predicted MRT values (MRT<sub>(pred)</sub>).</p>
<fig id="fig1-1091581811429865" position="float">
<label>Figure 1.</label>
<caption>
<p>Method of selection and development of final arithmetic expression. Y–the highest and/or significant R<sup>
<xref ref-type="bibr" rid="bibr2-1091581811429865">2</xref>
</sup> and <italic>Q</italic>
<sup>
<xref ref-type="bibr" rid="bibr2-1091581811429865">2</xref>
</sup> values → go to next <italic>in silico</italic> parameter; N–the lowest and/or significant R<sup>
<xref ref-type="bibr" rid="bibr2-1091581811429865">2</xref>
</sup> and <italic>Q</italic>
<sup>
<xref ref-type="bibr" rid="bibr2-1091581811429865">2</xref>
</sup> values → stop analysis.</p>
</caption>
<graphic alternate-form-of="fig1-1091581811429865" xlink:href="10.1177_1091581811429865-fig1.tif"/>
</fig>
<table-wrap id="table2-1091581811429865" position="float">
<label>Table 2.</label>
<caption>
<p>Examples of Arithmetic Expressions Created for Selected Physiochemical Parameters in the Group of 27 Drugs Administered Intravenously and Their Correlation With Mean Residence Time in Human and Dog</p>
</caption>
<graphic alternate-form-of="table2-1091581811429865" xlink:href="10.1177_1091581811429865-table2.tif"/>
<table>
<thead>
<tr>
<th rowspan="2">Arithmetic expressions</th>
<th colspan="2">
<italic>R</italic>
<sup>
<xref ref-type="bibr" rid="bibr2-1091581811429865">2</xref>
</sup>
</th>
</tr>
<tr>
<th>Man</th>
<th>Dog</th>
</tr>
</thead>
<tbody>
<tr>
<td>PSA</td>
<td>0.064</td>
<td>0.002</td>
</tr>
<tr>
<td>
<inline-formula id="inline-formula4-1091581811429865">
<mml:math id="mml-inline4-1091581811429865">
<mml:mo stretchy="false">[</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">L</mml:mi>
<mml:mi mathvariant="normal">o</mml:mi>
<mml:mi mathvariant="normal">g</mml:mi>
<mml:mo mathvariant="normal" stretchy="false">(</mml:mo>
<mml:mi mathvariant="normal">P</mml:mi>
<mml:mi mathvariant="normal">S</mml:mi>
<mml:mi mathvariant="normal">A</mml:mi>
<mml:mo mathvariant="normal" stretchy="false">)</mml:mo>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">]</mml:mo>
</mml:math>
</inline-formula>
</td>
<td>0.003</td>
<td>0.077</td>
</tr>
<tr>
<td>
<inline-formula id="inline-formula5-1091581811429865">
<mml:math id="mml-inline5-1091581811429865">
<mml:mo stretchy="false">[</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">L</mml:mi>
<mml:mi mathvariant="normal">o</mml:mi>
<mml:mi mathvariant="normal">g</mml:mi>
<mml:mo mathvariant="normal" stretchy="false">(</mml:mo>
<mml:mi mathvariant="normal">P</mml:mi>
<mml:mi mathvariant="normal">S</mml:mi>
<mml:mi mathvariant="normal">A</mml:mi>
<mml:mo mathvariant="normal" stretchy="false">−</mml:mo>
<mml:mi mathvariant="normal">W</mml:mi>
<mml:mi mathvariant="normal">P</mml:mi>
<mml:mi mathvariant="normal">S</mml:mi>
<mml:mi mathvariant="normal">A</mml:mi>
<mml:mo mathvariant="normal" stretchy="false">)</mml:mo>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">]</mml:mo>
</mml:math>
</inline-formula>
</td>
<td>0.014</td>
<td>0.090</td>
</tr>
<tr>
<td>
<inline-formula id="inline-formula6-1091581811429865">
<mml:math id="mml-inline6-1091581811429865">
<mml:mo stretchy="false">[</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">L</mml:mi>
<mml:mi mathvariant="normal">o</mml:mi>
<mml:mi mathvariant="normal">g</mml:mi>
<mml:mo mathvariant="normal" stretchy="false">(</mml:mo>
<mml:mi mathvariant="normal">P</mml:mi>
<mml:mi mathvariant="normal">S</mml:mi>
<mml:mi mathvariant="normal">A</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">−</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">W</mml:mi>
<mml:mi mathvariant="normal">P</mml:mi>
<mml:mi mathvariant="normal">S</mml:mi>
<mml:mi mathvariant="normal">A</mml:mi>
<mml:mo mathvariant="normal" stretchy="false">)</mml:mo>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">×</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mo mathvariant="normal" stretchy="false">(</mml:mo>
<mml:mi mathvariant="normal">X</mml:mi>
<mml:mi mathvariant="normal">L</mml:mi>
<mml:mi mathvariant="normal">o</mml:mi>
<mml:mi mathvariant="normal">g</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mi>P</mml:mi>
<mml:mo stretchy="false">−</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">L</mml:mi>
<mml:mi mathvariant="normal">o</mml:mi>
<mml:mi mathvariant="normal">g</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mi>K</mml:mi>
<mml:mi>p</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">]</mml:mo>
</mml:math>
</inline-formula>
</td>
<td>0.247</td>
<td>0.474</td>
</tr>
<tr>
<td>
<inline-formula id="inline-formula7-1091581811429865">
<mml:math id="mml-inline7-1091581811429865">
<mml:mo stretchy="false">[</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">L</mml:mi>
<mml:mi mathvariant="normal">o</mml:mi>
<mml:mi mathvariant="normal">g</mml:mi>
<mml:mo mathvariant="normal" stretchy="false">(</mml:mo>
<mml:mi mathvariant="normal">P</mml:mi>
<mml:mi mathvariant="normal">S</mml:mi>
<mml:mi mathvariant="normal">A</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">−</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">W</mml:mi>
<mml:mi mathvariant="normal">P</mml:mi>
<mml:mi mathvariant="normal">S</mml:mi>
<mml:mi mathvariant="normal">A</mml:mi>
<mml:mo mathvariant="normal" stretchy="false">)</mml:mo>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">×</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mo mathvariant="normal" stretchy="false">(</mml:mo>
<mml:mi mathvariant="normal">X</mml:mi>
<mml:mi mathvariant="normal">L</mml:mi>
<mml:mi mathvariant="normal">o</mml:mi>
<mml:mi mathvariant="normal">g</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mi>P</mml:mi>
<mml:mo stretchy="false">−</mml:mo>
<mml:mo stretchy="false">(</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">L</mml:mi>
<mml:mi mathvariant="normal">o</mml:mi>
<mml:mi mathvariant="normal">g</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mi>K</mml:mi>
<mml:mi>p</mml:mi>
<mml:mo stretchy="false">−</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">E</mml:mi>
<mml:mi mathvariant="normal">A</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">×</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">L</mml:mi>
<mml:mi mathvariant="normal">o</mml:mi>
<mml:mi mathvariant="normal">g</mml:mi>
<mml:mi mathvariant="normal">C</mml:mi>
<mml:mi mathvariant="normal">a</mml:mi>
<mml:mi mathvariant="normal">c</mml:mi>
<mml:mi mathvariant="normal">o</mml:mi>
<mml:mn mathvariant="normal">2</mml:mn>
<mml:mo mathvariant="normal" stretchy="false">)</mml:mo>
<mml:mo mathvariant="normal" stretchy="false">)</mml:mo>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">]</mml:mo>
</mml:math>
</inline-formula>
</td>
<td>0.365</td>
<td>0.641</td>
</tr>
<tr>
<td>
<inline-formula id="inline-formula8-1091581811429865">
<mml:math id="mml-inline8-1091581811429865">
<mml:mo stretchy="false">[</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">L</mml:mi>
<mml:mi mathvariant="normal">o</mml:mi>
<mml:mi mathvariant="normal">g</mml:mi>
<mml:mo mathvariant="normal" stretchy="false">(</mml:mo>
<mml:mi mathvariant="normal">P</mml:mi>
<mml:mi mathvariant="normal">S</mml:mi>
<mml:mi mathvariant="normal">A</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">−</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">W</mml:mi>
<mml:mi mathvariant="normal">P</mml:mi>
<mml:mi mathvariant="normal">S</mml:mi>
<mml:mi mathvariant="normal">A</mml:mi>
<mml:mo mathvariant="normal" stretchy="false">)</mml:mo>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">×</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mo mathvariant="normal" stretchy="false">(</mml:mo>
<mml:mi mathvariant="normal">X</mml:mi>
<mml:mi mathvariant="normal">L</mml:mi>
<mml:mi mathvariant="normal">o</mml:mi>
<mml:mi mathvariant="normal">g</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mi>P</mml:mi>
<mml:mo stretchy="false">−</mml:mo>
<mml:mo stretchy="false">(</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">L</mml:mi>
<mml:mi mathvariant="normal">o</mml:mi>
<mml:mi mathvariant="normal">g</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mi>K</mml:mi>
<mml:mi>p</mml:mi>
<mml:mo stretchy="false">−</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">E</mml:mi>
<mml:mi mathvariant="normal">A</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">×</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">L</mml:mi>
<mml:mi mathvariant="normal">n</mml:mi>
<mml:mo mathvariant="normal" stretchy="false">(</mml:mo>
<mml:mi mathvariant="normal">C</mml:mi>
<mml:mi mathvariant="normal">a</mml:mi>
<mml:mi mathvariant="normal">c</mml:mi>
<mml:mi mathvariant="normal">o</mml:mi>
<mml:mn mathvariant="normal">2</mml:mn>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">+</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">A</mml:mi>
<mml:mi mathvariant="normal">M</mml:mi>
<mml:mi mathvariant="normal">I</mml:mi>
<mml:mi mathvariant="normal">N</mml:mi>
<mml:mi mathvariant="normal">E</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">+</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">S</mml:mi>
<mml:mi mathvariant="normal">A</mml:mi>
<mml:mi mathvariant="normal">F</mml:mi>
<mml:mo mathvariant="normal" stretchy="false">)</mml:mo>
<mml:mo mathvariant="normal" stretchy="false">)</mml:mo>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">+</mml:mo>
<mml:mo stretchy="false">(</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">A</mml:mi>
<mml:mi mathvariant="normal">M</mml:mi>
<mml:mi mathvariant="normal">I</mml:mi>
<mml:mi mathvariant="normal">D</mml:mi>
<mml:mi mathvariant="normal">E</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">+</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">I</mml:mi>
<mml:mi mathvariant="normal">P</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">−</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">F</mml:mi>
<mml:mi mathvariant="normal">G</mml:mi>
<mml:mo mathvariant="normal" stretchy="false">)</mml:mo>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">]</mml:mo>
</mml:math>
</inline-formula>
</td>
<td>0.130</td>
<td>0.643</td>
</tr>
<tr>
<td>
<inline-formula id="inline-formula9-1091581811429865">
<mml:math id="mml-inline9-1091581811429865">
<mml:mo stretchy="false">[</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">L</mml:mi>
<mml:mi mathvariant="normal">o</mml:mi>
<mml:mi mathvariant="normal">g</mml:mi>
<mml:mo mathvariant="normal" stretchy="false">(</mml:mo>
<mml:mi mathvariant="normal">P</mml:mi>
<mml:mi mathvariant="normal">S</mml:mi>
<mml:mi mathvariant="normal">A</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">−</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">W</mml:mi>
<mml:mi mathvariant="normal">P</mml:mi>
<mml:mi mathvariant="normal">S</mml:mi>
<mml:mi mathvariant="normal">A</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">+</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">A</mml:mi>
<mml:mi mathvariant="normal">C</mml:mi>
<mml:mi mathvariant="normal">I</mml:mi>
<mml:mi mathvariant="normal">D</mml:mi>
<mml:mo mathvariant="normal" stretchy="false">)</mml:mo>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">×</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mo mathvariant="normal" stretchy="false">(</mml:mo>
<mml:mi mathvariant="normal">X</mml:mi>
<mml:mi mathvariant="normal">L</mml:mi>
<mml:mi mathvariant="normal">o</mml:mi>
<mml:mi mathvariant="normal">g</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mi>P</mml:mi>
<mml:mo stretchy="false">−</mml:mo>
<mml:mo stretchy="false">(</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">L</mml:mi>
<mml:mi mathvariant="normal">o</mml:mi>
<mml:mi mathvariant="normal">g</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mi>K</mml:mi>
<mml:mi>p</mml:mi>
<mml:mo stretchy="false">−</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">E</mml:mi>
<mml:mi mathvariant="normal">A</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">×</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">L</mml:mi>
<mml:mi mathvariant="normal">n</mml:mi>
<mml:mo mathvariant="normal" stretchy="false">(</mml:mo>
<mml:mi mathvariant="normal">C</mml:mi>
<mml:mi mathvariant="normal">a</mml:mi>
<mml:mi mathvariant="normal">c</mml:mi>
<mml:mi mathvariant="normal">o</mml:mi>
<mml:mn mathvariant="normal">2</mml:mn>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">+</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">A</mml:mi>
<mml:mi mathvariant="normal">M</mml:mi>
<mml:mi mathvariant="normal">I</mml:mi>
<mml:mi mathvariant="normal">N</mml:mi>
<mml:mi mathvariant="normal">E</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">+</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">S</mml:mi>
<mml:mi mathvariant="normal">A</mml:mi>
<mml:mi mathvariant="normal">F</mml:mi>
<mml:mo mathvariant="normal" stretchy="false">)</mml:mo>
<mml:mo mathvariant="normal" stretchy="false">)</mml:mo>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">+</mml:mo>
<mml:mo stretchy="false">(</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">A</mml:mi>
<mml:mi mathvariant="normal">M</mml:mi>
<mml:mi mathvariant="normal">I</mml:mi>
<mml:mi mathvariant="normal">D</mml:mi>
<mml:mi mathvariant="normal">E</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">+</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">I</mml:mi>
<mml:mi mathvariant="normal">P</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">−</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">F</mml:mi>
<mml:mi mathvariant="normal">G</mml:mi>
<mml:mo mathvariant="normal" stretchy="false">)</mml:mo>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">]</mml:mo>
</mml:math>
</inline-formula>
</td>
<td>0.181</td>
<td>0.689</td>
</tr>
<tr>
<td>
<inline-formula id="inline-formula10-1091581811429865">
<mml:math id="mml-inline10-1091581811429865">
<mml:mo stretchy="false">[</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">L</mml:mi>
<mml:mi mathvariant="normal">o</mml:mi>
<mml:mi mathvariant="normal">g</mml:mi>
<mml:mo mathvariant="normal" stretchy="false">(</mml:mo>
<mml:mi mathvariant="normal">P</mml:mi>
<mml:mi mathvariant="normal">S</mml:mi>
<mml:mi mathvariant="normal">A</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">−</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">W</mml:mi>
<mml:mi mathvariant="normal">P</mml:mi>
<mml:mi mathvariant="normal">S</mml:mi>
<mml:mi mathvariant="normal">A</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">+</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">A</mml:mi>
<mml:mi mathvariant="normal">C</mml:mi>
<mml:mi mathvariant="normal">I</mml:mi>
<mml:mi mathvariant="normal">D</mml:mi>
<mml:mo mathvariant="normal" stretchy="false">)</mml:mo>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">×</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mo mathvariant="normal" stretchy="false">(</mml:mo>
<mml:mi mathvariant="normal">X</mml:mi>
<mml:mi mathvariant="normal">L</mml:mi>
<mml:mi mathvariant="normal">o</mml:mi>
<mml:mi mathvariant="normal">g</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mi>P</mml:mi>
<mml:mo stretchy="false">−</mml:mo>
<mml:mo stretchy="false">(</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">L</mml:mi>
<mml:mi mathvariant="normal">o</mml:mi>
<mml:mi mathvariant="normal">g</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mi>K</mml:mi>
<mml:mi>p</mml:mi>
<mml:mo stretchy="false">−</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">E</mml:mi>
<mml:mi mathvariant="normal">A</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">×</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">L</mml:mi>
<mml:mi mathvariant="normal">n</mml:mi>
<mml:mo mathvariant="normal" stretchy="false">(</mml:mo>
<mml:mi mathvariant="normal">C</mml:mi>
<mml:mi mathvariant="normal">a</mml:mi>
<mml:mi mathvariant="normal">c</mml:mi>
<mml:mi mathvariant="normal">o</mml:mi>
<mml:mn mathvariant="normal">2</mml:mn>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">+</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">A</mml:mi>
<mml:mi mathvariant="normal">M</mml:mi>
<mml:mi mathvariant="normal">I</mml:mi>
<mml:mi mathvariant="normal">N</mml:mi>
<mml:mi mathvariant="normal">E</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">+</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">S</mml:mi>
<mml:mi mathvariant="normal">A</mml:mi>
<mml:mi mathvariant="normal">F</mml:mi>
<mml:mo mathvariant="normal" stretchy="false">)</mml:mo>
<mml:mo mathvariant="normal" stretchy="false">)</mml:mo>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">+</mml:mo>
<mml:mo stretchy="false">(</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">A</mml:mi>
<mml:mi mathvariant="normal">M</mml:mi>
<mml:mi mathvariant="normal">I</mml:mi>
<mml:mi mathvariant="normal">D</mml:mi>
<mml:mi mathvariant="normal">E</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">+</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">I</mml:mi>
<mml:mi mathvariant="normal">P</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">−</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">F</mml:mi>
<mml:mi mathvariant="normal">G</mml:mi>
<mml:mo mathvariant="normal" stretchy="false">)</mml:mo>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">−</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">L</mml:mi>
<mml:mi mathvariant="normal">n</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">(</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">M</mml:mi>
<mml:mi mathvariant="normal">W</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">+</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">P</mml:mi>
<mml:mi mathvariant="normal">I</mml:mi>
<mml:mi mathvariant="normal">S</mml:mi>
<mml:mi mathvariant="normal">A</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">]</mml:mo>
</mml:math>
</inline-formula>
</td>
<td>0.214</td>
<td>0.823</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn5-1091581811429865">
<p>Abbreviations: WPSA, weakly polar component of the SASA (halogens, P, and S); PSA, Van der Waals surface area of polar nitrogen and oxygen atoms; XLogP, partition coefficient octanol/water; LogKp, predicted skin permeability; Caco2, predicted apparent Caco2 cell permeability; EA, calculated electron affinity; AMINE, number of nonconjugated AMINE groups; AMIDE, number of nonconjugated amide groups; IP, calculated ionization potential; ACID, number of carboxylic acid groups; FG, number of reactive functional groups; SAF, solvent-accessible surface area of fluorine atoms; PISA, π (carbon and attached hydrogen) component of the SASA; MW, molecular weight of the molecule.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section6-1091581811429865">
<title>Statistical Analysis and Validation</title>
<p>A statistical analysis was performed using Microsoft Office Excel software. The polynomial correlation and regression analysis functions were used for the determination of a relationship between the mathematical model value and MRT. All correlations were confirmed by the Fischer test (confidence interval 95%) and the standard estimation error (SEE) was calculated (differences with <italic>P </italic>&lt; .05 were regarded as statistically significant). Goodness of fit was evaluated based on MRT and MRT<sub>(pred)</sub> values. The coefficient of determination (<italic>R</italic>
<sup>
<xref ref-type="bibr" rid="bibr2-1091581811429865">2</xref>
</sup>) of the observed versus predicted data was analyzed. The leave-one-out (LOO) method was used for model cross-validation. Squared cross-validated correlation coefficient (<italic>Q</italic>
<sup>
<xref ref-type="bibr" rid="bibr2-1091581811429865">2</xref>
</sup>) parameter and difference between <italic>Q</italic>
<sup>
<xref ref-type="bibr" rid="bibr2-1091581811429865">2</xref>
</sup> and <italic>R</italic>
<sup>
<xref ref-type="bibr" rid="bibr2-1091581811429865">2</xref>
</sup> was calculated as measure of the internal performance and model predictive ability. <italic>Q</italic>
<sup>
<xref ref-type="bibr" rid="bibr2-1091581811429865">2</xref>
</sup> was calculated according to the formula: <inline-formula id="inline-formula11-1091581811429865">
<mml:math id="mml-inline11-1091581811429865">
<mml:mrow>
<mml:msup>
<mml:mi>Q</mml:mi>
<mml:mn>2</mml:mn>
</mml:msup>
<mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:mrow><mml:mo>[</mml:mo> <mml:mrow>
<mml:mstyle displaystyle="true">
<mml:mo>∑</mml:mo> <mml:mrow>
<mml:mo stretchy="false">(</mml:mo><mml:msub>
<mml:mi>Y</mml:mi>
<mml:mrow>
<mml:mtext>obs</mml:mtext>
</mml:mrow>
</mml:msub>
<mml:mo>−</mml:mo><mml:mi>Y</mml:mi>
</mml:mrow>
</mml:mstyle><mml:msup>
<mml:mo stretchy="false">)</mml:mo>
<mml:mn>2</mml:mn>
</mml:msup>
<mml:mo>/</mml:mo><mml:mstyle displaystyle="true">
<mml:mo>∑</mml:mo> <mml:mrow>
<mml:msup>
<mml:mrow>
<mml:mo stretchy="false">(</mml:mo><mml:msub>
<mml:mi>Y</mml:mi>
<mml:mrow>
<mml:mtext>obs</mml:mtext>
</mml:mrow>
</mml:msub>
<mml:mo>−</mml:mo><mml:msub>
<mml:mi>Y</mml:mi>
<mml:mi>m</mml:mi>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
<mml:mn>2</mml:mn>
</mml:msup>
</mml:mrow>
</mml:mstyle>
</mml:mrow> <mml:mo>]</mml:mo></mml:mrow>
</mml:mrow>
</mml:math>
</inline-formula> were <italic>Y</italic>
<sub>obs</sub>—observed value for the <italic>i</italic>th object, <italic>Y</italic>—value of the <italic>ith</italic> object estimated by using a model, <italic>Y<sub>m</sub>
</italic>—average value of the training set.<sup><xref ref-type="bibr" rid="bibr49-1091581811429865">
49</xref></sup>
<sup>,<xref ref-type="bibr" rid="bibr50-1091581811429865">50</xref>
</sup>
</p>
</sec>
</sec>
<sec id="section7-1091581811429865">
<title>Results</title>
<p>For the tested group of drugs, no significant correlation was demonstrated between MRT values in human and dog; the <italic>R</italic>
<sup>
<xref ref-type="bibr" rid="bibr2-1091581811429865">2</xref>
</sup> for linear fit of logarithmically transformed MRT values for the 2 species was 0.4194 (<xref ref-type="fig" rid="fig2-1091581811429865">Figure 2</xref>
). The relationship between MRT and t<sub>1/2kel</sub> in both human and dog was found to be linear for the tested group of drugs (<xref ref-type="fig" rid="fig3-1091581811429865">Figure 3</xref>
).</p>
<fig id="fig2-1091581811429865" position="float">
<label>Figure 2.</label>
<caption>
<p>Linear correlation between logarithmically transformed values of mean residence time (LogMRT) in the tested group of 27 drugs administered intravenously in man and dog.</p>
</caption>
<graphic alternate-form-of="fig2-1091581811429865" xlink:href="10.1177_1091581811429865-fig2.tif"/>
</fig>
<fig id="fig3-1091581811429865" position="float">
<label>Figure 3.</label>
<caption>
<p>Linear correlation between logarithmically transformed values of mean residence time (LogMRT) and logarithmically transformed values of the half-life in the elimination phase (Log t<sub>1/2kel)</sub> in the tested group of 27 drugs administered intravenously in human (solid line) and dog (dashed line).</p>
</caption>
<graphic alternate-form-of="fig3-1091581811429865" xlink:href="10.1177_1091581811429865-fig3.tif"/>
</fig>
<p>In either of the tested species, no significant direct dependence between the MRT value and physicochemical parameters analyzed was detected for the tested group of drugs. The highest <italic>R</italic>
<sup>
<xref ref-type="bibr" rid="bibr2-1091581811429865">2</xref>
</sup> values obtained for the relationship between single physicochemical parameter and MRT were 0.3180 (AMIDE) and 0.1114 (FG) for the dog and human, respectively; however, they were also determined for different parameters in each of the species (<xref ref-type="table" rid="table3-1091581811429865">Table 3</xref>
).</p>
<table-wrap id="table3-1091581811429865" position="float">
<label>Table 3.</label>
<caption>
<p>Correlations of 14 Physiochemical Parameters Calculated In Silico With Mean Residence Time (MRT) Value for the Group of 27 Drugs Administered Intravenously in Human and Dog</p>
</caption>
<graphic alternate-form-of="table3-1091581811429865" xlink:href="10.1177_1091581811429865-table3.tif"/>
<table>
<thead>
<tr>
<th rowspan="2">No</th>
<th rowspan="2">Substance</th>
<th rowspan="2">XLogP</th>
<th rowspan="2">AMINE</th>
<th rowspan="2">ACID</th>
<th rowspan="2">AMIDE</th>
<th rowspan="2">FG</th>
<th>MW</th>
<th>PISA </th>
<th>WPSA</th>
<th>Caco2</th>
<th rowspan="2">LogKp</th>
<th>IP</th>
<th>EA</th>
<th rowspan="2">SAF</th>
<th>PSA</th>
</tr>
<tr>
<th>(Da)</th>
<th>(A<sup>
<xref ref-type="bibr" rid="bibr2-1091581811429865">2</xref>
</sup>)</th>
<th>(A<sup>
<xref ref-type="bibr" rid="bibr2-1091581811429865">2</xref>
</sup>)</th>
<th>(nm/s)</th>
<th>(ev)</th>
<th>(ev)</th>
<th>(A<sup>
<xref ref-type="bibr" rid="bibr2-1091581811429865">2</xref>
</sup>)</th>
</tr>
</thead>
<tbody>
<tr>
<td>1</td>
<td>Cyclosporine</td>
<td>7.5</td>
<td>0</td>
<td>0</td>
<td>11</td>
<td>0</td>
<td>1202.63</td>
<td>15.54</td>
<td>0</td>
<td>33.52</td>
<td>−0.65</td>
<td>9.35</td>
<td>−0.13</td>
<td>0</td>
<td>270.08</td>
</tr>
<tr>
<td>2</td>
<td>Amikacin</td>
<td>−7.9</td>
<td>4</td>
<td>0</td>
<td>1</td>
<td>2</td>
<td>585.61</td>
<td>0</td>
<td>0</td>
<td>0.01</td>
<td>−12.01</td>
<td>9.35</td>
<td>−1.05</td>
<td>0</td>
<td>323.59</td>
</tr>
<tr>
<td>3</td>
<td align="left">Pravastatin</td>
<td>1.6</td>
<td>0</td>
<td>1</td>
<td>0</td>
<td>1</td>
<td>424.53</td>
<td>92.7</td>
<td>0</td>
<td>17.11</td>
<td>−4.18</td>
<td>9.07</td>
<td>−0.09</td>
<td>0</td>
<td>140.2</td>
</tr>
<tr>
<td>4</td>
<td align="left">Carvedilol</td>
<td>4.2</td>
<td>1</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>406.48</td>
<td>450</td>
<td>0</td>
<td>485.31</td>
<td>−2.32</td>
<td>8.22</td>
<td>0.39</td>
<td>0</td>
<td>70.98</td>
</tr>
<tr>
<td>5</td>
<td align="left">Cefoperazone</td>
<td>−0.7</td>
<td>0</td>
<td>1</td>
<td>2</td>
<td>3</td>
<td>645.66</td>
<td>125.75</td>
<td>57.21</td>
<td>0.35</td>
<td>−6.94</td>
<td>9.27</td>
<td>1.6</td>
<td>0</td>
<td>271.86</td>
</tr>
<tr>
<td>6</td>
<td>Clindamycin</td>
<td>2.2</td>
<td>1</td>
<td>0</td>
<td>1</td>
<td>1</td>
<td>424.98</td>
<td>0</td>
<td>75.32</td>
<td>101.35</td>
<td>−5.02</td>
<td>9.1</td>
<td>0.23</td>
<td>0</td>
<td>100.22</td>
</tr>
<tr>
<td>7</td>
<td align="left">Cefamandole</td>
<td>−0.9</td>
<td>0</td>
<td>1</td>
<td>1</td>
<td>1</td>
<td>462.5</td>
<td>183.11</td>
<td>61.35</td>
<td>3.86</td>
<td>−5.29</td>
<td>9.54</td>
<td>1.46</td>
<td>0</td>
<td>182.14</td>
</tr>
<tr>
<td>8</td>
<td align="left">Albuterol</td>
<td>0.3</td>
<td>1</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>239.31</td>
<td>101.07</td>
<td>0</td>
<td>103.46</td>
<td>−5.14</td>
<td>8.92</td>
<td>−0.09</td>
<td>0</td>
<td>76.95</td>
</tr>
<tr>
<td>9</td>
<td>Tenofovir</td>
<td>−1.6</td>
<td>0</td>
<td>2</td>
<td>0</td>
<td>0</td>
<td>287.21</td>
<td>94.76</td>
<td>0</td>
<td>4.6</td>
<td>−4.58</td>
<td>8.59</td>
<td>0.21</td>
<td>0</td>
<td>126.08</td>
</tr>
<tr>
<td>10</td>
<td>Doxycycline</td>
<td>0</td>
<td>1</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>444.44</td>
<td>132.36</td>
<td>0</td>
<td>3.91</td>
<td>−7.85</td>
<td>9.04</td>
<td>0.64</td>
<td>0</td>
<td>188.01</td>
</tr>
<tr>
<td>11</td>
<td>Cefprozil</td>
<td>−1.4</td>
<td>1</td>
<td>1</td>
<td>1</td>
<td>1</td>
<td>389.43</td>
<td>163.2</td>
<td>29.79</td>
<td>1.48</td>
<td>−7.12</td>
<td>8.91</td>
<td>0.92</td>
<td>0</td>
<td>155.67</td>
</tr>
<tr>
<td>12</td>
<td>Probenecid</td>
<td>3.2</td>
<td>0</td>
<td>1</td>
<td>0</td>
<td>0</td>
<td>285.36</td>
<td>114.59</td>
<td>1.14</td>
<td>69.66</td>
<td>−3.47</td>
<td>9.92</td>
<td>1.3</td>
<td>0</td>
<td>86.93</td>
</tr>
<tr>
<td>13</td>
<td align="center">Buprenorphine</td>
<td>5</td>
<td>1</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>467.65</td>
<td>85.54</td>
<td>0</td>
<td>561.59</td>
<td>−3.86</td>
<td>8.72</td>
<td>−0.17</td>
<td>0</td>
<td>53.68</td>
</tr>
<tr>
<td>14</td>
<td>Quinidine</td>
<td>2.9</td>
<td>1</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>324.42</td>
<td>202.98</td>
<td>0</td>
<td>1047.72</td>
<td>−3.11</td>
<td>8.65</td>
<td>0.83</td>
<td>0</td>
<td>41.61</td>
</tr>
<tr>
<td>15</td>
<td>Cephalexin</td>
<td>0.6</td>
<td>1</td>
<td>1</td>
<td>1</td>
<td>1</td>
<td>347.39</td>
<td>185.57</td>
<td>31.87</td>
<td>4.52</td>
<td>−6.28</td>
<td>9.28</td>
<td>0.71</td>
<td>0</td>
<td>134.23</td>
</tr>
<tr>
<td>16</td>
<td>Ketoprofen</td>
<td>3.1</td>
<td>0</td>
<td>1</td>
<td>0</td>
<td>0</td>
<td>254.29</td>
<td>290.57</td>
<td>0</td>
<td>155.32</td>
<td>−2.46</td>
<td>9.87</td>
<td>0.67</td>
<td>0</td>
<td>75.28</td>
</tr>
<tr>
<td>17</td>
<td>Tramadol</td>
<td>2.6</td>
<td>1</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>263.38</td>
<td>98.72</td>
<td>0</td>
<td>1479.16</td>
<td>−3.29</td>
<td>8.83</td>
<td>−0.42</td>
<td>0</td>
<td>28.18</td>
</tr>
<tr>
<td>18</td>
<td>Butorphanol</td>
<td>3.8</td>
<td>1</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>327.47</td>
<td>94.9</td>
<td>0</td>
<td>441.58</td>
<td>−4.32</td>
<td>8.77</td>
<td>−0.25</td>
<td>0</td>
<td>42.75</td>
</tr>
<tr>
<td>19</td>
<td>Ketorolac</td>
<td>1.9</td>
<td>0</td>
<td>1</td>
<td>0</td>
<td>0</td>
<td>255.27</td>
<td>254.15</td>
<td>0</td>
<td>160.49</td>
<td>−2.66</td>
<td>9.36</td>
<td>0.48</td>
<td>0</td>
<td>77.51</td>
</tr>
<tr>
<td>20</td>
<td>Propofol</td>
<td>3.8</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>178.27</td>
<td>88.02</td>
<td>0</td>
<td>4824.87</td>
<td>−1.53</td>
<td>8.93</td>
<td>−0.26</td>
<td>0</td>
<td>18.94</td>
</tr>
<tr>
<td>21</td>
<td>Fosfomycin</td>
<td>−1.4</td>
<td>0</td>
<td>2</td>
<td>0</td>
<td>2</td>
<td>138.06</td>
<td>0</td>
<td>2.96</td>
<td>29.24</td>
<td>−3.84</td>
<td>10.36</td>
<td>−0.55</td>
<td>0</td>
<td>77.6</td>
</tr>
<tr>
<td>22</td>
<td align="center">Acetaminophen</td>
<td>0.5</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>151.17</td>
<td>166.2</td>
<td>0</td>
<td>843.28</td>
<td>−2.82</td>
<td>8.58</td>
<td>−0.02</td>
<td>0</td>
<td>61.22</td>
</tr>
<tr>
<td>23</td>
<td>Codeine</td>
<td>1.1</td>
<td>1</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>299.37</td>
<td>147.66</td>
<td>0</td>
<td>951.92</td>
<td>−3.68</td>
<td>8.49</td>
<td>−0.35</td>
<td>0</td>
<td>40.8</td>
</tr>
<tr>
<td>24</td>
<td>Morphine</td>
<td>0.8</td>
<td>1</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>285.34</td>
<td>147.03</td>
<td>0</td>
<td>255.06</td>
<td>−4.79</td>
<td>8.58</td>
<td>−0.31</td>
<td>0</td>
<td>57.81</td>
</tr>
<tr>
<td>25</td>
<td>Didanosine</td>
<td>−1.2</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>236.23</td>
<td>88.05</td>
<td>0</td>
<td>202.69</td>
<td>−4.31</td>
<td>8.76</td>
<td>0.09</td>
<td>0</td>
<td>102.09</td>
</tr>
<tr>
<td>26</td>
<td>Moxifloxacin</td>
<td>0.6</td>
<td>1</td>
<td>1</td>
<td>0</td>
<td>0</td>
<td>401.44</td>
<td>63.62</td>
<td>29.05</td>
<td>16.1</td>
<td>−6.26</td>
<td>8.45</td>
<td>0.8</td>
<td>29.05</td>
<td>99.19</td>
</tr>
<tr>
<td>27</td>
<td>Hydromorpho</td>
<td>1.8</td>
<td>1</td>
<td>0</td>
<td>0</td>
<td>1</td>
<td>285.34</td>
<td>86.47</td>
<td>0</td>
<td>244.93</td>
<td>−5.13</td>
<td>8.8</td>
<td>−0.09</td>
<td>0</td>
<td>64.22</td>
</tr>
<tr>
<td colspan="2">Minimum</td>
<td>−7.9</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>138.06</td>
<td>0</td>
<td>0</td>
<td>0.01</td>
<td>−12.01</td>
<td>8.22</td>
<td>−1.05</td>
<td>0</td>
<td>18.94</td>
</tr>
<tr>
<td colspan="2">Maximum</td>
<td>7.5</td>
<td>4</td>
<td>2</td>
<td>11</td>
<td>3</td>
<td>1202.63</td>
<td>450</td>
<td>75.32</td>
<td>4824.87</td>
<td>−0.65</td>
<td>10.36</td>
<td>1.6</td>
<td>29.05</td>
<td>323.59</td>
</tr>
<tr>
<td colspan="2">
<italic>R</italic>
<bold>
<sup>
<xref ref-type="bibr" rid="bibr2-1091581811429865">2</xref>
</sup> </bold>man </td>
<td align="center">0.0233</td>
<td align="center">0.0082</td>
<td align="center">0.041</td>
<td align="center">0.0011</td>
<td align="center">0.1114</td>
<td align="center">0.0189</td>
<td>0.0023</td>
<td align="center">0.0433</td>
<td align="center">0.0016</td>
<td align="center">0.0084</td>
<td align="center">0.0062</td>
<td align="center">0.0268</td>
<td align="center">0.0407</td>
<td align="center">0.0019</td>
</tr>
<tr>
<td colspan="2">
<italic>R</italic>
<bold>
<sup>
<xref ref-type="bibr" rid="bibr2-1091581811429865">2</xref>
</sup> </bold>dog </td>
<td align="center">0.188</td>
<td align="center">0.027</td>
<td align="center">0.0002</td>
<td align="center">0.318</td>
<td align="center">0.0925</td>
<td align="center">0.2908</td>
<td align="center">0.0131</td>
<td align="center">0.0096</td>
<td align="center">0.0349</td>
<td align="center">0.0452</td>
<td align="center">0.0469</td>
<td align="center">0.0606</td>
<td>0.0582</td>
<td align="center">0.0642</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn6-1091581811429865">
<p>Abbreviations: XLogP, octanol water partition coefficient; AMINE, number of nonconjugated amine groups; ACID, number of carboxylic acid groups; AMIDE, number of nonconjugated amide groups; FG, number of reactive functional groups; MW, molecular weight of the molecule; PISA, π (carbon and attached hydrogen) component of the solvent accessible surface area; WPSA, weakly polar component of the solvent accessible surface area (halogens, P, and S); Caco2, predicted apparent Caco2 cell permeability; LogKp, predicted skin permeability; IP, calculated ionization potential; EA, calculated electron affinity; SAF, solvent-accessible surface area of fluorine atoms; PSA, Van der Waals surface area of polar nitrogen and oxygen atoms; R<sup>
<xref ref-type="bibr" rid="bibr2-1091581811429865">2</xref>
</sup> human, determination coefficient between physiochemical parameters and MRT in man; R<sup>
<xref ref-type="bibr" rid="bibr2-1091581811429865">2</xref>
</sup> dog, determination coefficient between physiochemical parameters and MRT in dog.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>Of the 52 parameters analyzed, only 14 (XLogP, AMINE, ACID, AMIDE, FG, MW, PISA, WPSA, Caco2, LogKp, IP, EA, SAF, PSA; <xref ref-type="table" rid="table3-1091581811429865">Table 3</xref>) contributed value to the creation of the arithmetic expression, the value of which highly correlated with MRT. This expression was<disp-formula id="disp-formula2-1091581811429865">
<mml:math id="mml-disp2-1091581811429865">
<mml:mtable columnalign="right left" columnspacing="thickmathspace" displaystyle="true" rowspacing=".5em">
<mml:mtr>
<mml:mtd>
</mml:mtd>
<mml:mtd>
<mml:mi>L</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>g</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>P</mml:mi>
<mml:mi>S</mml:mi>
<mml:mi>A</mml:mi>
<mml:mo stretchy="false">−</mml:mo>
<mml:mi>W</mml:mi>
<mml:mi>P</mml:mi>
<mml:mi>S</mml:mi>
<mml:mi>A</mml:mi>
<mml:mo stretchy="false">+</mml:mo>
<mml:mi>A</mml:mi>
<mml:mi>C</mml:mi>
<mml:mi>I</mml:mi>
<mml:mi>D</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">×</mml:mo>
<mml:mo stretchy="false">[</mml:mo>
<mml:mi>X</mml:mi>
<mml:mi>L</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>g</mml:mi>
<mml:mi>P</mml:mi>
<mml:mo stretchy="false">−</mml:mo>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>L</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>g</mml:mi>
<mml:mi>K</mml:mi>
<mml:mi>p</mml:mi>
<mml:mo stretchy="false">−</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">E</mml:mi>
<mml:mi mathvariant="normal">A</mml:mi>
</mml:mrow>
</mml:mrow>
</mml:mtd>
</mml:mtr>
<mml:mtr>
<mml:mtd>
</mml:mtd>
<mml:mtd>
<mml:mo stretchy="false">×</mml:mo>
<mml:mi>L</mml:mi>
<mml:mi>n</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>C</mml:mi>
<mml:mi>a</mml:mi>
<mml:mi>c</mml:mi>
<mml:mi>o</mml:mi>
<mml:mn>2</mml:mn>
<mml:mo stretchy="false">+</mml:mo>
<mml:mi>A</mml:mi>
<mml:mi>M</mml:mi>
<mml:mi>I</mml:mi>
<mml:mi>N</mml:mi>
<mml:mi>E</mml:mi>
<mml:mo stretchy="false">+</mml:mo>
<mml:mi>S</mml:mi>
<mml:mi>A</mml:mi>
<mml:mi>F</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">]</mml:mo>
<mml:mo stretchy="false">+</mml:mo>
<mml:mo stretchy="false">+</mml:mo>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>A</mml:mi>
<mml:mi>M</mml:mi>
<mml:mi>I</mml:mi>
<mml:mi>D</mml:mi>
<mml:mi>E</mml:mi>
<mml:mo stretchy="false">+</mml:mo>
<mml:mi>I</mml:mi>
<mml:mi>P</mml:mi>
<mml:mo stretchy="false">−</mml:mo>
<mml:mi>F</mml:mi>
<mml:mi>G</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
</mml:mtd>
</mml:mtr>
<mml:mtr>
<mml:mtd>
</mml:mtd>
<mml:mtd>
<mml:mo stretchy="false">−</mml:mo>
<mml:mi>L</mml:mi>
<mml:mi>n</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>M</mml:mi>
<mml:mi>W</mml:mi>
<mml:mo stretchy="false">+</mml:mo>
<mml:mi>P</mml:mi>
<mml:mi>I</mml:mi>
<mml:mi>S</mml:mi>
<mml:mi>A</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
</mml:mtd>
</mml:mtr>
</mml:mtable>
</mml:math>
<graphic alternate-form-of="disp-formula2-1091581811429865" xlink:href="10.1177_1091581811429865-eq1.tif"/>
</disp-formula>
</p>
<p>For the polynomial fit, a correlation of statistical significance (<italic>P </italic>&lt; .001; <italic>R</italic>
<sup>
<xref ref-type="bibr" rid="bibr2-1091581811429865">2</xref> </sup>= .8227; <xref ref-type="fig" rid="fig4-1091581811429865">Figure 4</xref>
) was demonstrated between the arithmetic expression and MRT value in the dog. This correlation has been illustrated by the following equation: <inline-formula id="inline-formula12-1091581811429865">
<mml:math id="mml-inline12-1091581811429865">
<mml:mi>y</mml:mi>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>0.0518</mml:mn>
<mml:mo stretchy="false">×</mml:mo>
<mml:msup>
<mml:mi>x</mml:mi>
<mml:mn>2</mml:mn>
</mml:msup>
<mml:mo stretchy="false">−</mml:mo>
<mml:mn>0.9647</mml:mn>
<mml:mo stretchy="false">×</mml:mo>
<mml:mi>x</mml:mi>
<mml:mo stretchy="false">+</mml:mo>
<mml:mn>5.7561</mml:mn>
</mml:math>
</inline-formula>, where <inline-formula id="inline-formula13-1091581811429865">
<mml:math id="mml-inline13-1091581811429865">
<mml:mo stretchy="false">[</mml:mo>
<mml:mi>x</mml:mi>
<mml:mo stretchy="false">]</mml:mo>
</mml:math>
</inline-formula> was the value of the arithmetic expression created. When the values of the same arithmetic expression were correlated with MRT values in human, the significance of such correlation was found to be low (<italic>P </italic>&gt; .05; <italic>R</italic>
<sup>
<xref ref-type="bibr" rid="bibr2-1091581811429865">2</xref> </sup>= .2138; <xref ref-type="fig" rid="fig5-1091581811429865">Figure 5</xref>
). Values of the arithmetic expression and values of MRT<sub>(pred)</sub> calculated based on this expression are presented in <xref ref-type="table" rid="table4-1091581811429865">Table 4.</xref>
</p>
<fig id="fig4-1091581811429865" position="float">
<label>Figure 4.</label>
<caption>
<p>Polynomial correlation between values of mean residence time (MRT) and values of arithmetic expression
<disp-formula id="disp-formula3-1091581811429865">
<mml:math id="mml-disp3-1091581811429865">
<mml:mtable columnalign="right left" columnspacing="thickmathspace" displaystyle="true" rowspacing=".5em">
<mml:mtr>
<mml:mtd>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">L</mml:mi>
<mml:mi mathvariant="normal">o</mml:mi>
<mml:mi mathvariant="normal">g</mml:mi>
<mml:mo mathvariant="normal" stretchy="false">(</mml:mo>
<mml:mi mathvariant="normal">P</mml:mi>
<mml:mi mathvariant="normal">S</mml:mi>
<mml:mi mathvariant="normal">A</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">−</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">W</mml:mi>
<mml:mi mathvariant="normal">P</mml:mi>
<mml:mi mathvariant="normal">S</mml:mi>
<mml:mi mathvariant="normal">A</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">+</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">A</mml:mi>
<mml:mi mathvariant="normal">C</mml:mi>
<mml:mi mathvariant="normal">I</mml:mi>
<mml:mi mathvariant="normal">D</mml:mi>
<mml:mo mathvariant="normal" stretchy="false">)</mml:mo>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">×</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mo mathvariant="normal" stretchy="false">[</mml:mo>
<mml:mi mathvariant="normal">X</mml:mi>
<mml:mi mathvariant="normal">L</mml:mi>
<mml:mi mathvariant="normal">o</mml:mi>
<mml:mi mathvariant="normal">g</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mi>P</mml:mi>
<mml:mo stretchy="false">−</mml:mo>
<mml:mo stretchy="false">(</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">L</mml:mi>
<mml:mi mathvariant="normal">o</mml:mi>
<mml:mi mathvariant="normal">g</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mi>K</mml:mi>
<mml:mi>p</mml:mi>
<mml:mo stretchy="false">−</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">E</mml:mi>
<mml:mi mathvariant="normal">A</mml:mi>
</mml:mrow>
</mml:mrow>
</mml:mtd>
</mml:mtr>
<mml:mtr>
<mml:mtd>
<mml:mo stretchy="false">×</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">L</mml:mi>
<mml:mi mathvariant="normal">n</mml:mi>
<mml:mo mathvariant="normal" stretchy="false">(</mml:mo>
<mml:mi mathvariant="normal">C</mml:mi>
<mml:mi mathvariant="normal">a</mml:mi>
<mml:mi mathvariant="normal">c</mml:mi>
<mml:mi mathvariant="normal">o</mml:mi>
<mml:mn mathvariant="normal">2</mml:mn>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">+</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">A</mml:mi>
<mml:mi mathvariant="normal">M</mml:mi>
<mml:mi mathvariant="normal">I</mml:mi>
<mml:mi mathvariant="normal">N</mml:mi>
<mml:mi mathvariant="normal">E</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">+</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">S</mml:mi>
<mml:mi mathvariant="normal">A</mml:mi>
<mml:mi mathvariant="normal">F</mml:mi>
<mml:mo mathvariant="normal" stretchy="false">)</mml:mo>
<mml:mo mathvariant="normal" stretchy="false">)</mml:mo>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">]</mml:mo>
<mml:mo stretchy="false">+</mml:mo>
<mml:mo stretchy="false">(</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">A</mml:mi>
<mml:mi mathvariant="normal">M</mml:mi>
<mml:mi mathvariant="normal">I</mml:mi>
<mml:mi mathvariant="normal">D</mml:mi>
<mml:mi mathvariant="normal">E</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">+</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">I</mml:mi>
<mml:mi mathvariant="normal">P</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">−</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">F</mml:mi>
<mml:mi mathvariant="normal">G</mml:mi>
<mml:mo mathvariant="normal" stretchy="false">)</mml:mo>
</mml:mrow>
</mml:mrow>
</mml:mtd>
</mml:mtr>
<mml:mtr>
<mml:mtd>
<mml:mo stretchy="false">−</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">L</mml:mi>
<mml:mi mathvariant="normal">n</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">(</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">M</mml:mi>
<mml:mi mathvariant="normal">W</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">+</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">P</mml:mi>
<mml:mi mathvariant="normal">I</mml:mi>
<mml:mi mathvariant="normal">S</mml:mi>
<mml:mi mathvariant="normal">A</mml:mi>
<mml:mo mathvariant="normal" stretchy="false">)</mml:mo>
</mml:mrow>
</mml:mrow>
</mml:mtd>
</mml:mtr>
</mml:mtable>
</mml:math>
<graphic alternate-form-of="disp-formula3-1091581811429865" xlink:href="10.1177_1091581811429865-eq2.tif"/>
</disp-formula>
</p>
<p>constructed based on 14 selected physiochemical parameters in the tested group of 27 drugs administered intravenously in the dog.</p>
</caption>
<graphic alternate-form-of="fig4-1091581811429865" xlink:href="10.1177_1091581811429865-fig4.tif"/>
</fig>
<fig id="fig5-1091581811429865" position="float">
<label>Figure 5.</label>
<caption>
<p>Polynomial correlation between value of mean residence time (MRT) and value of arithmetic expression
<disp-formula id="disp-formula4-1091581811429865">
<mml:math id="mml-disp4-1091581811429865">
<mml:mtable columnalign="left">
<mml:mtr>
<mml:mtd>
<mml:mi>L</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>g</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>P</mml:mi>
<mml:mi>S</mml:mi>
<mml:mi>A</mml:mi>
<mml:mo>−</mml:mo>
<mml:mi>W</mml:mi>
<mml:mi>P</mml:mi>
<mml:mi>S</mml:mi>
<mml:mi>A</mml:mi>
<mml:mo>+</mml:mo>
<mml:mi>A</mml:mi>
<mml:mi>C</mml:mi>
<mml:mi>I</mml:mi>
<mml:mi>D</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>×</mml:mo>
<mml:mo stretchy="false">[</mml:mo>
<mml:mi>X</mml:mi>
<mml:mi>L</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>g</mml:mi>
<mml:mi>P</mml:mi>
<mml:mo>−</mml:mo>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>L</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>g</mml:mi>
<mml:mi>K</mml:mi>
<mml:mi>p</mml:mi>
<mml:mo>−</mml:mo>
<mml:mtext>EA</mml:mtext>
<mml:mo>×</mml:mo>
<mml:mi>L</mml:mi>
<mml:mi>n</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>C</mml:mi>
<mml:mi>a</mml:mi>
<mml:mi>c</mml:mi>
<mml:mi>o</mml:mi>
<mml:mn>2</mml:mn>
<mml:mo>+</mml:mo>
<mml:mi>A</mml:mi>
<mml:mi>M</mml:mi>
<mml:mi>I</mml:mi>
<mml:mi>N</mml:mi>
<mml:mi>E</mml:mi>
<mml:mo>+</mml:mo>
<mml:mi>S</mml:mi>
<mml:mi>A</mml:mi>
<mml:mi>F</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">]</mml:mo>
<mml:mo>+</mml:mo>
</mml:mtd>
</mml:mtr>
<mml:mtr>
<mml:mtd>
<mml:mo>+</mml:mo>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>A</mml:mi>
<mml:mi>M</mml:mi>
<mml:mi>I</mml:mi>
<mml:mi>D</mml:mi>
<mml:mi>E</mml:mi>
<mml:mo>+</mml:mo>
<mml:mi>I</mml:mi>
<mml:mi>P</mml:mi>
<mml:mo>−</mml:mo>
<mml:mi>F</mml:mi>
<mml:mi>G</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>−</mml:mo>
<mml:mi>L</mml:mi>
<mml:mi>n</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>M</mml:mi>
<mml:mi>W</mml:mi>
<mml:mo>+</mml:mo>
<mml:mi>P</mml:mi>
<mml:mi>I</mml:mi>
<mml:mi>S</mml:mi>
<mml:mi>A</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
</mml:mtd>
</mml:mtr>
</mml:mtable>
</mml:math>
<graphic alternate-form-of="disp-formula4-1091581811429865" xlink:href="10.1177_1091581811429865-eq2.tif"/>
</disp-formula>
</p>
<p>constructed based on the selected 14 physiochemical parameters in the tested group of 27 drugs administered intravenously in human.</p>
</caption>
<graphic alternate-form-of="fig5-1091581811429865" xlink:href="10.1177_1091581811429865-fig5.tif"/>
</fig>
<table-wrap id="table4-1091581811429865" position="float">
<label>Table 4.</label>
<caption>
<p>Values of the Arithmetic Expression <inline-formula id="inline-formula14-1091581811429865">
<mml:math id="mml-inline14-1091581811429865">
<mml:mo stretchy="false">[</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">L</mml:mi>
<mml:mi mathvariant="normal">o</mml:mi>
<mml:mi mathvariant="normal">g</mml:mi>
<mml:mo mathvariant="normal" stretchy="false">(</mml:mo>
<mml:mi mathvariant="normal">P</mml:mi>
<mml:mi mathvariant="normal">S</mml:mi>
<mml:mi mathvariant="normal">A</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">−</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">W</mml:mi>
<mml:mi mathvariant="normal">P</mml:mi>
<mml:mi mathvariant="normal">S</mml:mi>
<mml:mi mathvariant="normal">A</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">+</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">A</mml:mi>
<mml:mi mathvariant="normal">C</mml:mi>
<mml:mi mathvariant="normal">I</mml:mi>
<mml:mi mathvariant="normal">D</mml:mi>
<mml:mo mathvariant="normal" stretchy="false">)</mml:mo>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">×</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mo mathvariant="normal" stretchy="false">[</mml:mo>
<mml:mi mathvariant="normal">X</mml:mi>
<mml:mi mathvariant="normal">L</mml:mi>
<mml:mi mathvariant="normal">o</mml:mi>
<mml:mi mathvariant="normal">g</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mi>P</mml:mi>
<mml:mo stretchy="false">−</mml:mo>
<mml:mo stretchy="false">(</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">L</mml:mi>
<mml:mi mathvariant="normal">o</mml:mi>
<mml:mi mathvariant="normal">g</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mi>K</mml:mi>
<mml:mi>p</mml:mi>
<mml:mo stretchy="false">−</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">E</mml:mi>
<mml:mi mathvariant="normal">A</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">×</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">L</mml:mi>
<mml:mi mathvariant="normal">n</mml:mi>
<mml:mo mathvariant="normal" stretchy="false">(</mml:mo>
<mml:mi mathvariant="normal">C</mml:mi>
<mml:mi mathvariant="normal">a</mml:mi>
<mml:mi mathvariant="normal">c</mml:mi>
<mml:mi mathvariant="normal">o</mml:mi>
<mml:mn mathvariant="normal">2</mml:mn>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">+</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">A</mml:mi>
<mml:mi mathvariant="normal">M</mml:mi>
<mml:mi mathvariant="normal">I</mml:mi>
<mml:mi mathvariant="normal">N</mml:mi>
<mml:mi mathvariant="normal">E</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">+</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">S</mml:mi>
<mml:mi mathvariant="normal">A</mml:mi>
<mml:mi mathvariant="normal">F</mml:mi>
<mml:mo mathvariant="normal" stretchy="false">)</mml:mo>
<mml:mo mathvariant="normal" stretchy="false">)</mml:mo>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">]</mml:mo>
<mml:mo stretchy="false">+</mml:mo>
<mml:mo stretchy="false">(</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">A</mml:mi>
<mml:mi mathvariant="normal">M</mml:mi>
<mml:mi mathvariant="normal">I</mml:mi>
<mml:mi mathvariant="normal">D</mml:mi>
<mml:mi mathvariant="normal">E</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">+</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">I</mml:mi>
<mml:mi mathvariant="normal">P</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">−</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">F</mml:mi>
<mml:mi mathvariant="normal">G</mml:mi>
<mml:mo mathvariant="normal" stretchy="false">)</mml:mo>
</mml:mrow>
<mml:mo mathvariant="normal" stretchy="false">−</mml:mo>
<mml:mi mathvariant="normal">L</mml:mi>
<mml:mi mathvariant="normal">n</mml:mi>
<mml:mo mathvariant="normal" stretchy="false">(</mml:mo>
<mml:mi mathvariant="normal">M</mml:mi>
<mml:mi mathvariant="normal">W</mml:mi>
<mml:mo mathvariant="normal" stretchy="false">+</mml:mo>
<mml:mi mathvariant="normal">P</mml:mi>
<mml:mi mathvariant="normal">I</mml:mi>
<mml:mi mathvariant="normal">S</mml:mi>
<mml:mi mathvariant="normal">A</mml:mi>
<mml:mo mathvariant="normal" stretchy="false">)</mml:mo>
</mml:mrow>
<mml:mo stretchy="false">]</mml:mo>
</mml:math>
</inline-formula> and of the Mean Residence Time Predicted (MRT<sub>(pred)</sub>) Calculated Based on This Expression in the Tested Group of 27 Drugs Administered Intravenously in Human and Dog</p>
</caption>
<graphic alternate-form-of="table4-1091581811429865" xlink:href="10.1177_1091581811429865-table4.tif"/>
<table>
<thead>
<tr>
<th rowspan="2">No.</th>
<th rowspan="2">Substance</th>
<th rowspan="2">Arithmetic Expression Value</th>
<th>Man</th>
<th>Dog</th>
</tr>
<tr>
<th>MRT(pred),  hours</th>
<th>MRT(pred), hours</th>
</tr>
</thead>
<tbody>
<tr>
<td>1</td>
<td>Cyclosporine</td>
<td>31.95</td>
<td>12.15</td>
<td>27.802</td>
</tr>
<tr>
<td>2</td>
<td>Amikacin</td>
<td>8.63</td>
<td>2.78</td>
<td>1.29</td>
</tr>
<tr>
<td>3</td>
<td>Pravastatin</td>
<td>13.71</td>
<td>3.96</td>
<td>2.27</td>
</tr>
<tr>
<td>4</td>
<td>Carvedilol</td>
<td>18.04</td>
<td>5.34</td>
<td>5.21</td>
</tr>
<tr>
<td>5</td>
<td>Cefoperazone</td>
<td>12.28</td>
<td>3.58</td>
<td>1.72</td>
</tr>
<tr>
<td>6</td>
<td>Clindamycin</td>
<td>14.61</td>
<td>4.22</td>
<td>2.72</td>
</tr>
<tr>
<td>7</td>
<td>Cefamandole</td>
<td>16.34</td>
<td>4.76</td>
<td>3.83</td>
</tr>
<tr>
<td>8</td>
<td>Albuterol</td>
<td>12.58</td>
<td>3.65</td>
<td>1.82</td>
</tr>
<tr>
<td>9</td>
<td>Tenofovir</td>
<td>9.6</td>
<td>2.97</td>
<td>1.27</td>
</tr>
<tr>
<td>10</td>
<td>Doxycycline</td>
<td>22.87</td>
<td>7.3</td>
<td>10.78</td>
</tr>
<tr>
<td>11</td>
<td>Cefprozil</td>
<td>16.38</td>
<td>4.77</td>
<td>3.85</td>
</tr>
<tr>
<td>12</td>
<td>Probenecid</td>
<td>27.54</td>
<td>9.61</td>
<td>18.48</td>
</tr>
<tr>
<td>13</td>
<td>Buprenorphine</td>
<td>15.91</td>
<td>4.62</td>
<td>3.52</td>
</tr>
<tr>
<td>14</td>
<td>Quinidine</td>
<td>21.44</td>
<td>6.67</td>
<td>8.88</td>
</tr>
<tr>
<td>15</td>
<td>Cephalexin</td>
<td>19.29</td>
<td>5.81</td>
<td>6.42</td>
</tr>
<tr>
<td>16</td>
<td>Ketoprofen</td>
<td>20.4</td>
<td>6.24</td>
<td>7.63</td>
</tr>
<tr>
<td>17</td>
<td>Tramadol</td>
<td>7.07</td>
<td>2.51</td>
<td>1.53</td>
</tr>
<tr>
<td>18</td>
<td>Butorphanol</td>
<td>13.45</td>
<td>3.89</td>
<td>2.15</td>
</tr>
<tr>
<td>19</td>
<td>Ketorolac</td>
<td>16.42</td>
<td>4.79</td>
<td>3.88</td>
</tr>
<tr>
<td>20</td>
<td>Propofol</td>
<td>7.39</td>
<td>2.56</td>
<td>1.46</td>
</tr>
<tr>
<td>21</td>
<td>Fosfomycin</td>
<td>4.53</td>
<td>2.17</td>
<td>2.45</td>
</tr>
<tr>
<td>22</td>
<td>Acetaminophen</td>
<td>8.46</td>
<td>2.75</td>
<td>1.3</td>
</tr>
<tr>
<td>23</td>
<td>Codeine</td>
<td>6.23</td>
<td>2.39</td>
<td>1.76</td>
</tr>
<tr>
<td>24</td>
<td>Morphine</td>
<td>9.35</td>
<td>2.91</td>
<td>1.26</td>
</tr>
<tr>
<td>25</td>
<td>Didanosine</td>
<td>10.18</td>
<td>3.09</td>
<td>1.3</td>
</tr>
<tr>
<td>26</td>
<td>Moxifloxacin</td>
<td>20.71</td>
<td>6.37</td>
<td>7.99</td>
</tr>
<tr>
<td>27</td>
<td>Hydromorphone</td>
<td>13.47</td>
<td>3.89</td>
<td>2.16</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn7-1091581811429865">
<p>Abbreviations: XLogP, octanol water partition coefficient; AMINE, number of nonconjugated amine groups; acid, number of carboxylic acid groups; AMIDE, number of nonconjugated amide groups; FG, number of reactive functional groups; MW, molecular weight of the molecule; PISA, π (carbon and attached hydrogen) component of the solvent-accessible surface area; WPSA, weakly polar component of the solvent accessible surface area (halogens, P, and S); Caco2, predicted apparent Caco2 cell permeability; LogKp, predicted skin permeability; IP, calculated ionization potential; EA, calculated electron affinity; SAF, solvent-accessible surface area of fluorine atoms; PSA, Van der Waals surface area of polar nitrogen and oxygen atoms.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>The linear correlation between MRT and MRT<sub>(pred)</sub> in dog and human is shown in <xref ref-type="fig" rid="fig6-1091581811429865">Figure 6</xref>. The dependence between MRT and MRT<sub>(pred)</sub> values was found significant only in the case of the dog (<italic>F</italic> = 116.03; SEE = 2.84; <italic>P </italic>&lt; .001; <italic>Q</italic>
<sup>
<xref ref-type="bibr" rid="bibr2-1091581811429865">2</xref> </sup>= 0.666). In dog, differences between <italic>R</italic>
<sup>
<xref ref-type="bibr" rid="bibr2-1091581811429865">2</xref>
</sup> and q<sup>
<xref ref-type="bibr" rid="bibr2-1091581811429865">2</xref>
</sup> did not exceed 0.3, which confirms that the model was not overfitted and did not have irrelevant values or outliers in the data. Statistically significant dependence was not found for human (<italic>F</italic> = 6.80; SEE = 2.09; <italic>P </italic>&gt; .05; <italic>Q</italic>
<sup>
<xref ref-type="bibr" rid="bibr2-1091581811429865">2</xref> </sup>= 0.525); Moreover, the difference between <italic>R</italic>
<sup>
<xref ref-type="bibr" rid="bibr2-1091581811429865">2</xref>
</sup> and <italic>Q</italic>
<sup>
<xref ref-type="bibr" rid="bibr2-1091581811429865">2</xref>
</sup> (&lt;.3) demonstrated that the model based on human data was overfitted. The result of the F test (MRT\MRT<sub>(pred)</sub>) was 17 times higher in case of data obtained for the dog than for the data obtained for human.</p>
<fig id="fig6-1091581811429865" position="float">
<label>Figure 6.</label>
<caption>
<p>Linear correlation between values of mean residence time (MRT) and values of mean residence time predicted (MRT<sub>(pred)</sub>) in the tested group of 27 drugs administered intravenously both in dog (A) and human (B).</p>
</caption>
<graphic alternate-form-of="fig6-1091581811429865" xlink:href="10.1177_1091581811429865-fig6.tif"/>
</fig>
<sec id="section8-1091581811429865">
<title>Discussion</title>
<p>The analysis of a relationship between the molecular structure of the drug (in relation to single physicochemical parameters) and MRT value did not render any significant correlation neither in humans nor in the dog. However, such correlation has been observed for the arithmetic expression created based on several physicochemical characteristics for the group of drugs used in the dog. The existence of a correlation between a mathematical model derived from multiple measured parameters (illustrating a complicated chemical composition of a molecule) and not for single physicochemical parameters of drugs reflects in a way a complicated nature of processes described by the MRT. On the other hand, it must be pointed out that for the group of drugs analyzed, no significant correlation between MRT values for human and dog was detected. The lack of such correlation is consistent with allometrical scaling analysis performed by Ward and Smith.<sup><xref ref-type="bibr" rid="bibr51-1091581811429865">
51</xref>,<xref ref-type="bibr" rid="bibr52-1091581811429865">52</xref>
</sup> in which the authors showed that the dog is not a good general model for human MRT analysis. The above findings indicate that pharmacokinetic processes, to which drugs are submitted within the body, vary significantly between the species. Studies which are conducted to analyze the relationship between physicochemical parameters of drugs and pharmacokinetic parameters determined in vivo are usually performed on a limited amount of data. This is in particular the case of studies, in which a search for a relationship between the chemical composition of a drug and parameters related to drug elimination such as t<sub>1/2kel</sub> and clearance is conducted. There are some studies in which a correlation has been investigated for renal and nonrenal clearance versus octanol/water partition coefficient. These were performed on a small group of drugs with similar chemical composition and pharmacodynamic properties. Calculations conducted by Hinderling et al<sup><xref ref-type="bibr" rid="bibr14-1091581811429865">
14
</xref></sup> were based on 12 homologs and the coefficient of correlation for the polynomial equation was below 0.9. In other studies, the analysis has been conducted for 6 different homologs and the correlation of octanol/water partition coefficient and renal clearance was determined to be 0.96.<sup><xref ref-type="bibr" rid="bibr15-1091581811429865">15</xref></sup> However, it should be taken into account that it is very difficult at best extrapolate an analysis of this type to bigger groups of drugs with differentiated chemical structure and pharmacokinetic as well as pharmacodynamic properties.</p>
<p>A trend to use complex equations and mathematical models, as in the present study, has been established in scientific research and used at earlier stages for other pharmacokinetic parameters, for example, volume of distribution.<sup><xref ref-type="bibr" rid="bibr11-1091581811429865">
11
</xref></sup> A correlation with an mathematical model based on several physicochemical parameters has also been demonstrated for the NOEL (no observed effect level) parameter value for the group of 135 drugs.<sup><xref ref-type="bibr" rid="bibr53-1091581811429865">
53
</xref><xref ref-type="bibr" rid="bibr54-1091581811429865"/>–
<xref ref-type="bibr" rid="bibr55-1091581811429865">
55</xref></sup>
</p>
<p>In conclusion, it can be stated that the present study constitutes an attempt to find a correlation between the value of MRT and MRT<sub>(pred)</sub>, a value derived from an optimal set of multiple physicochemical parameters determined in silico and combined in one arithmetic expression. Although such correlation was demonstrated and validated for the dog, analogical calculations performed for the data obtained in human could not be successfully predicted. The results of the present in silico analysis demonstrate that the extrapolation of pharmacokinetic data from the dog to human, particularly in relation to MRT, has significant limitations.</p>
</sec>
</sec>
</body>
<back>
<ack>
<title>Acknowledgements</title>
<p>The authors thank Professor Witold GumuŁka for the critical reading of the manuscript.</p>
</ack>
<fn-group>
<fn fn-type="conflict" id="fn1-1091581811429865">
<p>The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p>
</fn>
<fn fn-type="financial-disclosure" id="fn2-1091581811429865">
<p>The author(s) received no financial support for the research, authorship, and/or publication of this article.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-1091581811429865">
<label>1</label>
<citation citation-type="book">
<collab collab-type="author">EMEA</collab>. <article-title>Guidance for industry Bioavailability and bioequivalence studies for orally administered drug products-general considerations</article-title>; <year>2003</year>: <fpage>1</fpage>–<lpage>21</lpage>.</citation>
</ref>
<ref id="bibr2-1091581811429865">
<label>2</label>
<citation citation-type="book">
<collab collab-type="author">FDA</collab>. <article-title>Guidance for Industry Bioanalytical Method Validation</article-title>; <year>2001</year>: <fpage>1</fpage>–<lpage>20</lpage>.</citation>
</ref>
<ref id="bibr3-1091581811429865">
<label>3</label>
<citation citation-type="book">
<collab collab-type="author">EMEA</collab>. <article-title>Note for Guidance: Approach towards harmonisation of withdrawal periods</article-title>; <year>1996</year>: <fpage>7</fpage>–<lpage>36</lpage>.</citation>
</ref>
<ref id="bibr4-1091581811429865">
<label>4</label>
<citation citation-type="book">
<collab collab-type="author">EMEA</collab>. <article-title>Note for Guidance on the investigation of bioavailability and bioequivalence</article-title>; <year>2001</year>: <fpage>1</fpage>–<lpage>17</lpage>.</citation>
</ref>
<ref id="bibr5-1091581811429865">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Roy</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Lau</surname>
<given-names>CE</given-names>
</name>
</person-group>. <article-title>A double-peak phenomenon in the pharmacokinetics of alprazolam after oral administration</article-title>. <source>Drug Metab Dispos</source>. <year>1999</year>; <volume>27</volume>(<issue>8</issue>): <fpage>855</fpage>–<lpage>859</lpage>.</citation>
</ref>
<ref id="bibr6-1091581811429865">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tan</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>BK</given-names>
</name>
<name>
<surname>Jackson</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Swift</surname>
<given-names>CG</given-names>
</name>
<name>
<surname>Hutt</surname>
<given-names>AJ</given-names>
</name>
</person-group>. <article-title>Stereoselectivity of ibuprofen metabolism and pharmacokinetics following the administration of the racemate to healthy volunteers</article-title>. <source>Xenobiotica</source>. <year>2002</year>; <volume>32</volume>(<issue>8</issue>): <fpage>683</fpage>–<lpage>697</lpage>.</citation>
</ref>
<ref id="bibr7-1091581811429865">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weitschies</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Bernsdorf</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Giessmann</surname>
<given-names>T</given-names>
</name>
<etal/>
</person-group> <article-title>The talinolol double-peak phenomenon is likely caused by presystemic processing after uptake from gut lumen</article-title>. <source>Pharm Res</source>. <year>2005</year>; <volume>22</volume>(<issue>5</issue>): <fpage>728</fpage>–<lpage>735</lpage>.</citation>
</ref>
<ref id="bibr8-1091581811429865">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Feng</surname>
<given-names>B</given-names>
</name>
<name>
<surname>LaPerle</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Varma</surname>
<given-names>MV</given-names>
</name>
</person-group>. <article-title>Renal clearance in drug discovery and development: molecular descriptors, drug transporters and disease state</article-title>. <source>Expert Opin Drug Metab Toxicol</source>. <year>2010</year>; <volume>6</volume>(<issue>8</issue>): <fpage>939</fpage>–<lpage>952</lpage>.</citation>
</ref>
<ref id="bibr9-1091581811429865">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Gandhi</surname>
<given-names>YA</given-names>
</name>
<name>
<surname>Duignan</surname>
<given-names>DB</given-names>
</name>
<name>
<surname>Morris</surname>
<given-names>ME</given-names>
</name>
</person-group>. <article-title>Prediction of biliary excretion in rats and humans using molecular weight and quantitative structure-pharmacokinetic relationships</article-title>. <source>AAPS J</source>. <year>2009</year>; <volume>11</volume>(<issue>3</issue>): <fpage>511</fpage>–<lpage>525</lpage>.</citation>
</ref>
<ref id="bibr10-1091581811429865">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Cameron</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Guzman-Perez</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Perry</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>H</given-names>
</name>
</person-group>. <article-title>Structure-pharmacokinetic relationship of in vivo rat biliary excretion</article-title>. <source>Biopharm Drug Dispos</source>. <year>2010</year>; <volume>31</volume>(<issue>1</issue>): <fpage>82</fpage>–<lpage>90</lpage>.</citation>
</ref>
<ref id="bibr11-1091581811429865">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ghafourian</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Barzegar-Jalali</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Dastmalchi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Khavari-Khorasani</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Hakimiha</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Nokhodchi</surname>
<given-names>A</given-names>
</name>
</person-group>. <article-title>QSPR models for the prediction of apparent volume of distribution</article-title>. <source>Int J Pharm</source>. <year>2006</year>; <volume>319</volume>(<issue>1-2</issue>): <fpage>82</fpage>–<lpage>97</lpage>.</citation>
</ref>
<ref id="bibr12-1091581811429865">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gleeson</surname>
<given-names>MP</given-names>
</name>
<name>
<surname>Waters</surname>
<given-names>NJ</given-names>
</name>
<name>
<surname>Paine</surname>
<given-names>SW</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>AM</given-names>
</name>
</person-group>. <article-title>In silico human and rat vs quantitative structure-activity relationship models</article-title>. <source>J Med Chem</source>. <year>2006</year>; <volume>49</volume>(<issue>6</issue>): <fpage>1953</fpage>–<lpage>1963</lpage>.</citation>
</ref>
<ref id="bibr13-1091581811429865">
<label>13</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Gibaldi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Perrier</surname>
<given-names>D</given-names>
</name>
</person-group>. <source>Pharmacokinetics</source>. <publisher-loc>New York, NY</publisher-loc>: <publisher-name>Marcel Dekker, Inc</publisher-name>; <year>1982</year>.</citation>
</ref>
<ref id="bibr14-1091581811429865">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hinderling</surname>
<given-names>PH</given-names>
</name>
<name>
<surname>Schmidlin</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Seydel</surname>
<given-names>JK</given-names>
</name>
</person-group>. <article-title>Quantitative relationships between structure and pharmacokinetics of betaadrenoceptor blocking agents in man</article-title>. <source>J Pharmacokinet Biopharm</source>. <year>1984</year>; <volume>12</volume>(<issue>3</issue>): <fpage>263</fpage>–<lpage>287</lpage>.</citation>
</ref>
<ref id="bibr15-1091581811429865">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mager</surname>
<given-names>DE</given-names>
</name>
</person-group>. <article-title>Quantitative structure-pharmacokinetic/pharmacodynamic relationships</article-title>. <source>Adv Drug Deliv Rev</source>. <year>2006</year>; <volume>58</volume>(<issue>12-13</issue>): <fpage>1326</fpage>–<lpage>1356</lpage>.</citation>
</ref>
<ref id="bibr16-1091581811429865">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname>
<given-names>MJ</given-names>
</name>
</person-group>. <article-title>Predicting total clearance in humans from chemical structure</article-title>. <source>J Chem Inf Model</source>. <year>2010</year>; <volume>50</volume>(<issue>7</issue>): <fpage>1284</fpage>–<lpage>1295</lpage>.</citation>
</ref>
<ref id="bibr17-1091581811429865">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goel</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Sinha</surname>
<given-names>VR</given-names>
</name>
<name>
<surname>Thareja</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Aggarwal</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>M</given-names>
</name>
</person-group>. <article-title>Assessment of biological half life using in silico QSPkR approach: a self organizing molecular field analysis (SOMFA) on a series of antimicrobial quinolone drugs</article-title>. <source>Int J Pharm</source>. <year>2011</year>; <volume>415</volume>(<issue>1-2</issue>): <fpage>158</fpage>–<lpage>163</lpage>.</citation>
</ref>
<ref id="bibr18-1091581811429865">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Clark</surname>
<given-names>DE</given-names>
</name>
</person-group>. <article-title>Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 1. Prediction of intestinal absorption</article-title>. <source>J Pharm Sci</source>. <year>1999</year>; <volume>88</volume>(<issue>8</issue>): <fpage>807</fpage>–<lpage>814</lpage>.</citation>
</ref>
<ref id="bibr19-1091581811429865">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grabowski</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Jaroszewski</surname>
<given-names>JJ</given-names>
</name>
</person-group>. <article-title>Bioavailability of veterinary drugs in vivo and in silico</article-title>. <source>J Vet Pharmacol Ther</source>. <year>2009</year>; <volume>32</volume>(<issue>3</issue>): <fpage>249</fpage>–<lpage>257</lpage>.</citation>
</ref>
<ref id="bibr20-1091581811429865">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hou</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J</given-names>
</name>
</person-group>. <article-title>Recent developments of in silico predictions of intestinal absorption and oral bioavailability</article-title>. <source>Comb Chem High Throughput Screen</source>. <year>2009</year>; <volume>12</volume>(<issue>5</issue>): <fpage>497</fpage>–<lpage>506</lpage>.</citation>
</ref>
<ref id="bibr21-1091581811429865">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Melagraki</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Afantitis</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sarimveis</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Igglessi-Markopoulou</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Koutentis</surname>
<given-names>PA</given-names>
</name>
<name>
<surname>Kollias</surname>
<given-names>G</given-names>
</name>
</person-group>. <article-title>In silico exploration for identifying structure-activity relationship of MEK inhibition and oral bioavailability for isothiazole derivatives</article-title>. <source>Chem Biol Drug Des</source>. <year>2010</year>; <volume>76</volume>(<issue>5</issue>): <fpage>397</fpage>–<lpage>406</lpage>.</citation>
</ref>
<ref id="bibr22-1091581811429865">
<label>22</label>
<citation citation-type="book">
<collab collab-type="author">NCBI</collab>. <article-title>National Center for Biotechnology Information, U.S. National Library of Medicine</article-title>, <ext-link ext-link-type="uri" xlink:href="www.pubmed.com">www.pubmed.com</ext-link>; <year>2010</year>.</citation>
</ref>
<ref id="bibr23-1091581811429865">
<label>23</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Kubinyi</surname>
<given-names>H</given-names>
</name>
</person-group>. <article-title>QSAR: Hansch Analysis and Related Approaches</article-title>. <publisher-loc>Weinheim, Germany</publisher-loc>
<publisher-name>: VCH</publisher-name>,; <year>1993</year>: <fpage>91</fpage>–<lpage>109</lpage>.</citation>
</ref>
<ref id="bibr24-1091581811429865">
<label>24</label>
<citation citation-type="book">
<collab collab-type="author">WHO</collab>. <article-title>Guidance Document On The Validation Of (Quantitative)Structure-Activity Relationships [(Q)SAR] Models</article-title>. <comment>ENV/JM/MONO(2007)2</comment>; <year>2007</year>: <fpage>2</fpage>–<lpage>135</lpage>.</citation>
</ref>
<ref id="bibr25-1091581811429865">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ward</surname>
<given-names>KW</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>BR</given-names>
</name>
</person-group>. <article-title>A comprehensive quantitative and qualitative evaluation of extrapolation of intravenous pharmacokinetic parameters from rat, dog, and monkey to humans. I. Clearance</article-title>. <source>Drug Metab Dispos</source>. <year>2004a</year>; <volume>32</volume>(<issue>6</issue>): <fpage>603</fpage>–<lpage>611</lpage>.</citation>
</ref>
<ref id="bibr26-1091581811429865">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ward</surname>
<given-names>KW</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>BR</given-names>
</name>
</person-group>. <article-title>A comprehensive quantitative and qualitative evaluation of extrapolation of intravenous pharmacokinetic parameters from rat, dog, and monkey to humans. II. Volume of distribution and mean residence time</article-title>. <source>Drug Metab Dispos</source>. <year>2004b</year>; <volume>32</volume>(<issue>6</issue>): <fpage>612</fpage>–<lpage>619</lpage>.</citation>
</ref>
<ref id="bibr27-1091581811429865">
<label>27</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Enslein</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Tomb</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Lander</surname>
<given-names>TR</given-names>
</name>
</person-group>. <article-title>Structure-activity models of biological oxygen demand, in QSAR</article-title>. In: <person-group person-group-type="editor">
<name>
<surname>Kaiser</surname>
<given-names>KLE</given-names>
</name>
</person-group>, ed. <source>Environmental Toxicology</source>. <publisher-loc>Dordrecht</publisher-loc>: <publisher-name>Reidel</publisher-name>; <year>1984; 1-6</year>.</citation>
</ref>
<ref id="bibr28-1091581811429865">
<label>28</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Kubinyi</surname>
<given-names>H</given-names>
</name>
</person-group>. <article-title>The quantitative analysis of structure-activity relationships</article-title>, In: <source>Burger’s Medicinal Chemistry</source>. <volume>Vol I</volume>, <year>1995</year>: <fpage>495</fpage>–<lpage>572</lpage>.</citation>
</ref>
<ref id="bibr29-1091581811429865">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grabowski</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Jaroszewski</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Piotrowski</surname>
<given-names>W</given-names>
</name>
</person-group>. <article-title>Correlations between no observed effect level and selected parameters of the chemical structure for veterinary drugs</article-title>. <source>Toxicol In Vitro</source>. <year>2010</year>; <volume>24</volume>(<issue>3</issue>): <fpage>953</fpage>–<lpage>959</lpage>.</citation>
</ref>
<ref id="bibr30-1091581811429865">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Obach</surname>
<given-names>RS</given-names>
</name>
<name>
<surname>Lombardo</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Waters</surname>
<given-names>NJ</given-names>
</name>
</person-group>. <article-title>Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds</article-title>. <source>Drug Metab Dispos</source>. <year>2008</year>; <volume>36</volume>(<issue>7</issue>): <fpage>1385</fpage>–<lpage>1405</lpage>.</citation>
</ref>
<ref id="bibr31-1091581811429865">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alkharfy</surname>
<given-names>KM</given-names>
</name>
</person-group>. <article-title>Influence of overt diabetes mellitus on cyclosporine pharmacokinetics in a canine model</article-title>. <source>Exp Diabetes Res</source>. <year>2009</year>; <fpage>89-109</fpage>. <comment>doi: 10.1155/2009/363787</comment>
</citation>
</ref>
<ref id="bibr32-1091581811429865">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kukanich</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Coetzee</surname>
<given-names>JF</given-names>
</name>
</person-group>. <article-title>Comparative pharmacokinetics of amikacin in Greyhound and Beagle dogs</article-title>. <source>J Vet Pharmacol Ther</source>. <year>2008</year>; <volume>31</volume>(<issue>2</issue>): <fpage>102</fpage>–<lpage>107</lpage>.</citation>
</ref>
<ref id="bibr33-1091581811429865">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morrison</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Singhvi</surname>
<given-names>SM</given-names>
</name>
</person-group>. <article-title>Pharmacokinetics and oral bioavailability of pravastatin in dogs</article-title>. <source>Int J Pharm</source>. <year>1996</year>; <volume>143</volume>(<issue>2</issue>): <fpage>265</fpage>–<lpage>269</lpage>.</citation>
</ref>
<ref id="bibr34-1091581811429865">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arsenault</surname>
<given-names>WG</given-names>
</name>
<name>
<surname>Boothe</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Gordon</surname>
<given-names>SG</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>MW</given-names>
</name>
<name>
<surname>Chalkley</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Petrikovics</surname>
<given-names>I</given-names>
</name>
</person-group>. <article-title>Pharmacokinetics of carvedilol after intravenous and oral administration in conscious healthy dogs</article-title>. <source>Am J Vet Res</source>. <year>2005</year>; <volume>66</volume>(<issue>12</issue>): <fpage>2172</fpage>–<lpage>2176</lpage>.</citation>
</ref>
<ref id="bibr35-1091581811429865">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Montesissa</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Villa</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Anfossi</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Zanoni</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Carli</surname>
<given-names>S</given-names>
</name>
</person-group>. <article-title>Pharmacodynamics and pharmacokinetics of cefoperazone and cefamandole in dogs following single dose intravenous and intramuscular administration</article-title>. <source>Vet J</source>. <year>2003</year>; <volume>166</volume>(<issue>2</issue>): <fpage>170</fpage>–<lpage>176</lpage>.</citation>
</ref>
<ref id="bibr36-1091581811429865">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Batzias</surname>
<given-names>GC</given-names>
</name>
<name>
<surname>Delis</surname>
<given-names>GA</given-names>
</name>
<name>
<surname>Athanasiou</surname>
<given-names>LV</given-names>
</name>
</person-group>. <article-title>Clindamycin bioavailability and pharmacokinetics following oral administration of clindamycin hydrochloride capsules in dogs</article-title>. <source>Vet J</source>. <year>2005</year>; <volume>170</volume>(<issue>3</issue>): <fpage>339</fpage>–<lpage>345</lpage>.</citation>
</ref>
<ref id="bibr37-1091581811429865">
<label>37</label>
<citation citation-type="web">
<person-group person-group-type="author">
<name>
<surname>Vaughan</surname>
<given-names>DF</given-names>
</name>
</person-group>. <article-title>Pharmacokinetics of albuterol and butorphanol administered intravenously and via a buccal patch</article-title>. <comment>Thesis</comment>: <ext-link ext-link-type="uri" xlink:href="http://repository.tamu.edu/bitstream/handle/1969/391/etd-tamu-2003A-2003032721-Vaug-1.pdf?">http://repository.tamu.edu/bitstream/handle/1969/391/etd-tamu-2003A-2003032721-Vaug-1.pdf?</ext-link>. sequence=1.<year>2003</year>; <fpage>1</fpage>–<lpage>117</lpage>
</citation>
</ref>
<ref id="bibr38-1091581811429865">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cundy</surname>
<given-names>KC</given-names>
</name>
<name>
<surname>Sueoka</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Lynch</surname>
<given-names>GR</given-names>
</name>
<name>
<surname>Griffin</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>WA</given-names>
</name>
<name>
<surname>Shaw</surname>
<given-names>JP</given-names>
</name>
</person-group>. <article-title>Pharmacokinetics and bioavailability of the anti-human immunodeficiency virus nucleotide analog 9-[(R)-2-(phosphonomethoxy)propyl]adenine (PMPA) in dogs</article-title>. <source>Antimicrob Agents Chemother</source>. <year>1998</year>; <volume>42</volume>(<issue>3</issue>): <fpage>687</fpage>–<lpage>690</lpage>.</citation>
</ref>
<ref id="bibr39-1091581811429865">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wilson</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Kemp</surname>
<given-names>DT</given-names>
</name>
<name>
<surname>Kitzman</surname>
<given-names>JV</given-names>
</name>
<name>
<surname>Goetsch</surname>
<given-names>DD</given-names>
</name>
</person-group>. <article-title>Pharmacokinetics of doxycycline in dogs</article-title>. <source>Can J Vet Res</source>. <year>1988</year>; <volume>52</volume>(<issue>1</issue>): <fpage>12</fpage>–<lpage>14</lpage>.</citation>
</ref>
<ref id="bibr40-1091581811429865">
<label>40</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barbhaiya</surname>
<given-names>RH</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Shyu</surname>
<given-names>WC</given-names>
</name>
<name>
<surname>Pittman</surname>
<given-names>KA</given-names>
</name>
</person-group>. <article-title>Absolute bioavailability of cefprozil after oral administration in beagles</article-title>. <source>Antimicrob Agents Chemother</source>. <year>1992</year>; <volume>36</volume>(<issue>3</issue>): <fpage>687</fpage>–<lpage>689</lpage>.</citation>
</ref>
<ref id="bibr41-1091581811429865">
<label>41</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kakizaki</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Yokoyama</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Natsuhori</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group> <article-title>Probenecid: its chromatographic determination, plasma protein binding, and in vivo pharmacokinetics in dogs</article-title>. <source>J Vet Med Sci</source>. <year>2006</year>; <volume>68</volume>(<issue>4</issue>): <fpage>361</fpage>–<lpage>365</lpage>.</citation>
</ref>
<ref id="bibr42-1091581811429865">
<label>42</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krotscheck</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Boothe</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Little</surname>
<given-names>AA</given-names>
</name>
</person-group>. <article-title>Pharmacokinetics of buprenorphine following intravenous administration in dogs</article-title>. <source>Vet Ther</source>. <year>2008</year>; <volume>9</volume>(<issue>2</issue>): <fpage>83</fpage>–<lpage>93</lpage>.</citation>
</ref>
<ref id="bibr43-1091581811429865">
<label>43</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kuroha</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Shirai</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Shimoda</surname>
<given-names>M</given-names>
</name>
</person-group>. <article-title>Multiple oral dosing of ketoconazole influences pharmacokinetics of quinidine after intravenous and oral administration in beagle dogs</article-title>. <source>J Vet Pharmacol Ther</source>. <year>2004</year>; <volume>27</volume>(<issue>5</issue>): <fpage>355</fpage>–<lpage>359</lpage>.</citation>
</ref>
<ref id="bibr44-1091581811429865">
<label>44</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carli</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Anfossi</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Villa</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Castellani</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Mengozzi</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Montesissa</surname>
<given-names>C</given-names>
</name>
</person-group>. <article-title>Absorption kinetics and bioavailability of cephalexin in the dog after oral and intramuscular administration</article-title>. <source>J Vet Pharmacol Ther</source>. <year>1999</year>; <volume>22</volume>(<issue>5</issue>): <fpage>308</fpage>–<lpage>313</lpage>.</citation>
</ref>
<ref id="bibr45-1091581811429865">
<label>45</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Granero</surname>
<given-names>GE</given-names>
</name>
<name>
<surname>Amidon</surname>
<given-names>GL</given-names>
</name>
</person-group>. <article-title>Possibility of enterohepatic recycling of ketoprofen in dogs</article-title>. <source>Int J Pharm</source>. <year>2008</year>; <volume>349</volume>(<issue>1-2</issue>): <fpage>166</fpage>–<lpage>171</lpage>.</citation>
</ref>
<ref id="bibr46-1091581811429865">
<label>46</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vettorato</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Zonca</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Isola</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group> <article-title>Pharmacokinetics and efficacy of intravenous and extradural tramadol in dogs</article-title>. <source>Vet J</source>. <year>2010</year>; <volume>183</volume>(<issue>3</issue>): <fpage>310</fpage>–<lpage>315</lpage>.</citation>
</ref>
<ref id="bibr47-1091581811429865">
<label>47</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pasloske</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Renaud</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Burger</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Conlon</surname>
<given-names>P</given-names>
</name>
</person-group>. <article-title>Pharmacokinetics of ketorolac after intravenous and oral single dose administration in dogs</article-title>. <source>J Vet Pharmacol Ther</source>. <year>1999</year>; <volume>22</volume>(<issue>5</issue>): <fpage>314</fpage>–<lpage>319</lpage>.</citation>
</ref>
<ref id="bibr48-1091581811429865">
<label>48</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reid</surname>
<given-names>J</given-names>
</name>
</person-group>. <article-title>Pharmacokinetics of propofol as an induction agent in geriatric dogs</article-title>. <source>Res Vet Sci</source>. <year>1996</year>; <volume>61</volume>(<issue>2</issue>): <fpage>169</fpage>–<lpage>171</lpage>.</citation>
</ref>
<ref id="bibr49-1091581811429865">
<label>49</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gutierrez</surname>
<given-names>OL</given-names>
</name>
<name>
<surname>Ocampo</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Aguilera</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Luna</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Sumano</surname>
<given-names>LH</given-names>
</name>
</person-group>. <article-title>Pharmacokinetics of disodium-fosfomycin in mongrel dogs</article-title>. <source>Res Vet Sci</source>. <year>2008</year>; <volume>85</volume>(<issue>1</issue>): <fpage>156</fpage>–<lpage>161</lpage>.</citation>
</ref>
<ref id="bibr50-1091581811429865">
<label>50</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Neirinckx</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Vervaet</surname>
<given-names>C</given-names>
</name>
<name>
<surname>De Boever</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group> <article-title>Species comparison of oral bioavailability, first-pass metabolism and pharmacokinetics of acetaminophen</article-title>. <source>Res Vet Sci</source>. <year>2010</year>; <volume>89</volume>(<issue>1</issue>): <fpage>113</fpage>–<lpage>119</lpage>.</citation>
</ref>
<ref id="bibr51-1091581811429865">
<label>51</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kukanich</surname>
<given-names>B</given-names>
</name>
</person-group>. <article-title>Pharmacokinetics of acetaminophen, codeine, and the codeine metabolites morphine and codeine-6-glucuronide in healthy Greyhound dogs</article-title>. <source>J Vet Pharmacol Ther</source>. <year>2010</year>; <volume>33</volume>(<issue>1</issue>): <fpage>15</fpage>–<lpage>21</lpage>.</citation>
</ref>
<ref id="bibr52-1091581811429865">
<label>52</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kukanich</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Lascelles</surname>
<given-names>BDX</given-names>
</name>
<name>
<surname>Papich</surname>
<given-names>MG</given-names>
</name>
</person-group>. <article-title>Pharmacokinetics of morphine and plasma concentrations of morphine-6-glucuronide following morphine administration to dogs</article-title>. <source>J J Vet Pharmacol Ther</source>. <year>2005</year>; <volume>28</volume>(<issue>4</issue>): <fpage>371</fpage>–<lpage>376</lpage>.</citation>
</ref>
<ref id="bibr53-1091581811429865">
<label>53</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kaul</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Knupp</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Dandekar</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Pittman</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Barbhaiya</surname>
<given-names>RH</given-names>
</name>
</person-group>. <article-title>Pharmacokinetics of 2',3'-Dideoxyinosine (BMY-40900), a new anti-human immunodeficiency virus agent, after administration of single intravenous doses to beagle dogs</article-title>. <source>Antimicrob Agents Chemother</source>. <year>1991</year>; <volume>35</volume>(<issue>4</issue>): <fpage>610</fpage>–<lpage>614</lpage>.</citation>
</ref>
<ref id="bibr54-1091581811429865">
<label>54</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Siefert</surname>
<given-names>HM</given-names>
</name>
<name>
<surname>Domdey-Bette</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Henninger</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Hucke</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Kohlsdorfer</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Stass</surname>
<given-names>HH</given-names>
</name>
</person-group>. <article-title>Pharmacokinetics of the 8-methoxyquinolone, moxifloxacin: a comparison in humans and other mammalian species</article-title>. <source>J Antimicrob Chemother</source>. <year>1999</year>; <volume>43</volume>(<issue>suppl B</issue>): <fpage>69</fpage>–<lpage>76</lpage>.</citation>
</ref>
<ref id="bibr55-1091581811429865">
<label>55</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kukanich</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Hogan</surname>
<given-names>BK</given-names>
</name>
<name>
<surname>Krugner-Higby</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>LJ</given-names>
</name>
</person-group>. <article-title>Pharmacokinetics of hydromorphone hydrochloride in healthy dogs</article-title>. <source>Vet Anaesth Analg</source>. <year>2008</year>; <volume>35</volume>(<issue>3</issue>): <fpage>256</fpage>–<lpage>264</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>